| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.93e-06 | 18 | 243 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.75e-05 | 5 | 243 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.00e-05 | 28 | 243 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DHX36 HSP90B1 ATP6V1E1 ERCC6L ACSL1 ABCG2 DNA2 DNAH5 DNAH6 DNAH9 DNAH10 SMCHD1 ACSM4 GET3 DNAH17 ATP6V0A4 HELZ2 UBA6 TOP2A | 6.71e-05 | 614 | 243 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.12e-05 | 37 | 243 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 9.53e-05 | 8 | 243 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 2.73e-04 | 11 | 243 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine-6-sulfatase activity | 4.39e-04 | 3 | 243 | 2 | GO:0008449 | |
| GeneOntologyMolecularFunction | GTPase inhibitor activity | 4.65e-04 | 13 | 243 | 3 | GO:0005095 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 5.87e-04 | 14 | 243 | 3 | GO:0008401 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.03e-05 | 25 | 250 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | chromosomal region | DHX36 ERCC6L CLASP2 NCAPG MKI67 DNA2 DNMT1 RANGAP1 CLASP1 SMCHD1 PPP2R5A KMT5B CENPI PRKDC TOP2A HDAC2 | 5.14e-05 | 421 | 250 | 16 | GO:0098687 |
| GeneOntologyCellularComponent | cytoplasmic region | IFT140 TOGARAM1 CLASP2 PIK3C3 DNAH5 DNAH6 DNAH9 RANGAP1 SPEF1 DNAH10 CLASP1 GRIA2 ODAD2 DNAH17 | 1.19e-04 | 360 | 250 | 14 | GO:0099568 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.35e-04 | 9 | 250 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 1.94e-04 | 45 | 250 | 5 | GO:0099524 | |
| GeneOntologyCellularComponent | axoneme | IFT140 TOGARAM1 PIK3C3 DNAH5 DNAH6 DNAH9 SPEF1 DNAH10 ODAD2 DNAH17 | 2.04e-04 | 207 | 250 | 10 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | IFT140 TOGARAM1 PIK3C3 DNAH5 DNAH6 DNAH9 SPEF1 DNAH10 ODAD2 DNAH17 | 2.12e-04 | 208 | 250 | 10 | GO:0097014 |
| GeneOntologyCellularComponent | lysosome | ATP6V1E1 SIDT1 PSMD1 FYCO1 TINAGL1 SERPINB13 CPQ PIK3C3 SERPINB3 VPS13A PLD1 GNS VAT1 VPS39 EPG5 USP6 MTOR PRELP ATP6V0A4 LRP2 IL1B HCK | 3.15e-04 | 811 | 250 | 22 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ATP6V1E1 SIDT1 PSMD1 FYCO1 TINAGL1 SERPINB13 CPQ PIK3C3 SERPINB3 VPS13A PLD1 GNS VAT1 VPS39 EPG5 USP6 MTOR PRELP ATP6V0A4 LRP2 IL1B HCK | 3.15e-04 | 811 | 250 | 22 | GO:0000323 |
| GeneOntologyCellularComponent | outer dynein arm | 3.43e-04 | 12 | 250 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | dynein complex | 4.61e-04 | 54 | 250 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | IFT140 TOGARAM1 PIK3C3 DNAH5 DNAH6 DNAH9 RANGAP1 SPEF1 DNAH10 GRIA2 ODAD2 DNAH17 | 4.62e-04 | 317 | 250 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | chromosome, centromeric region | ERCC6L CLASP2 NCAPG MKI67 DNMT1 RANGAP1 CLASP1 PPP2R5A KMT5B CENPI TOP2A | 5.17e-04 | 276 | 250 | 11 | GO:0000775 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 5.58e-04 | 14 | 250 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | vacuole | ATP6V1E1 SIDT1 PSMD1 FYCO1 TINAGL1 SERPINB13 CPQ PIK3C3 SERPINB3 VPS13A PLD1 GNS VAT1 VPS39 YWHAB EPG5 USP6 MTOR PRELP ATP6V0A4 LRP2 IL1B HCK | 6.46e-04 | 913 | 250 | 23 | GO:0005773 |
| GeneOntologyCellularComponent | microtubule | DCDC1 IQGAP2 TOGARAM1 CLASP2 IQGAP1 DLG1 DNAH5 DNAH6 DNAH9 SPEF1 DNAH10 CLASP1 IGBP1 DNAH17 EIF3A MX2 | 7.28e-04 | 533 | 250 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | cell projection membrane | CLASP2 HCN2 C2CD5 SLC39A6 DLG1 ABCG2 UTRN CACNA1D GRIA2 ACE2 ATP6V0A4 LRP2 DMTN TCTN2 | 7.31e-04 | 431 | 250 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | apical plasma membrane | IL10RA ATP6V1E1 IQGAP1 SLC39A6 DLG1 ABCG2 PLD1 SLC23A1 CACNA1D SPEF1 ACE2 SLC15A1 SLC15A2 ATP6V0A4 LRP2 | 8.20e-04 | 487 | 250 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | zeta DNA polymerase complex | 8.41e-04 | 4 | 250 | 2 | GO:0016035 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 1.39e-03 | 5 | 250 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | cytosolic region | 1.51e-03 | 70 | 250 | 5 | GO:0099522 | |
| GeneOntologyCellularComponent | DNA polymerase complex | 1.66e-03 | 20 | 250 | 3 | GO:0042575 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SELENOT CYP3A7 HSP90B1 CYP3A4 CYP3A5 ANO5 PTGFRN AWAT1 RYR3 ELOVL7 ACSL1 NOMO2 SGPL1 PI4KB VPS13A DLG1 PLD1 CAMK2D LDAF1 MYRFL NOMO1 FADS1 ERGIC3 MTOR GET3 DHRS7C SLC33A1 NOMO3 | 1.74e-03 | 1293 | 250 | 28 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SELENOT CYP3A7 HSP90B1 CYP3A4 CYP3A5 ANO5 PTGFRN AWAT1 RYR3 ELOVL7 ACSL1 NOMO2 SGPL1 PI4KB VPS13A DLG1 PLD1 CAMK2D LDAF1 MYRFL NOMO1 FADS1 ERGIC3 MTOR GET3 DHRS7C SLC33A1 NOMO3 | 1.86e-03 | 1299 | 250 | 28 | GO:0098827 |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 2.07e-03 | 6 | 250 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | apical part of cell | IL10RA ATP6V1E1 USP9X IQGAP1 SLC39A6 DLG1 ABCG2 PLD1 SLC23A1 CACNA1D SPEF1 ACE2 SLC15A1 SLC15A2 ATP6V0A4 LRP2 | 2.14e-03 | 592 | 250 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | 9+2 motile cilium | VPS13A PCDH11X DNAH5 DNAH6 DNAH9 SPEF1 DNAH10 PCDH11Y DNAH17 | 2.35e-03 | 238 | 250 | 9 | GO:0097729 |
| GeneOntologyCellularComponent | endocytic vesicle | HSP90B1 PIK3C3 PLD1 CAMK2D GRIA2 ECPAS TFRC ACE2 SLC15A2 MTOR ATP6V0A4 LRP2 | 2.38e-03 | 384 | 250 | 12 | GO:0030139 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SELENOT CYP3A7 HSP90B1 CYP3A4 CYP3A5 ANO5 PTGFRN AWAT1 RYR3 ELOVL7 ACSL1 NOMO2 SGPL1 PI4KB VPS13A DLG1 PLD1 CAMK2D LDAF1 MYRFL NOMO1 FADS1 ERGIC3 MTOR GET3 DHRS7C SLC33A1 NOMO3 | 2.53e-03 | 1327 | 250 | 28 | GO:0042175 |
| Domain | ARM-type_fold | USP9X PSMD1 TOGARAM1 CLASP2 LYST RYR3 FOCAD DOCK5 NCAPG PIK3C3 PUM3 AGBL1 IPO5 CLASP1 MROH2A HEATR1 ODAD2 ECPAS PPP2R5A PPP2R5E CSE1L MTOR PRKDC | 1.84e-10 | 339 | 249 | 23 | IPR016024 |
| Domain | HEAT_REPEAT | TOGARAM1 CLASP2 NCAPG IPO5 CLASP1 MROH2A HEATR1 ODAD2 ECPAS MTOR PRKDC | 2.05e-09 | 70 | 249 | 11 | PS50077 |
| Domain | ARM-like | USP9X PSMD1 TOGARAM1 CLASP2 NCAPG PUM3 AGBL1 IPO5 RANGAP1 CLASP1 MROH2A HEATR1 ODAD2 ECPAS PPP2R5A PPP2R5E CSE1L MTOR PRKDC | 4.10e-09 | 270 | 249 | 19 | IPR011989 |
| Domain | HEAT | TOGARAM1 CLASP2 NCAPG IPO5 CLASP1 HEATR1 ODAD2 ECPAS MTOR PRKDC | 4.41e-09 | 58 | 249 | 10 | IPR000357 |
| Domain | - | USP9X PSMD1 TOGARAM1 CLASP2 NCAPG PUM3 IPO5 CLASP1 HEATR1 ODAD2 ECPAS PPP2R5E CSE1L MTOR PRKDC | 3.13e-07 | 222 | 249 | 15 | 1.25.10.10 |
| Domain | HEAT | 3.18e-06 | 48 | 249 | 7 | PF02985 | |
| Domain | DUF2012 | 9.27e-06 | 4 | 249 | 3 | PF09430 | |
| Domain | LRRC37AB_C | 9.27e-06 | 4 | 249 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 9.27e-06 | 4 | 249 | 3 | PF14914 | |
| Domain | DUF2012 | 9.27e-06 | 4 | 249 | 3 | IPR019008 | |
| Domain | LRRC37 | 9.27e-06 | 4 | 249 | 3 | PF15779 | |
| Domain | LRRC37_N | 9.27e-06 | 4 | 249 | 3 | IPR032754 | |
| Domain | LRRC37A/B-like | 9.27e-06 | 4 | 249 | 3 | IPR015753 | |
| Domain | Cyt_P450_E_grp-II | 2.30e-05 | 5 | 249 | 3 | IPR002402 | |
| Domain | ATPase_dyneun-rel_AAA | 2.78e-05 | 14 | 249 | 4 | IPR011704 | |
| Domain | MT | 2.78e-05 | 14 | 249 | 4 | PF12777 | |
| Domain | AAA_8 | 2.78e-05 | 14 | 249 | 4 | PF12780 | |
| Domain | AAA_5 | 2.78e-05 | 14 | 249 | 4 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.78e-05 | 14 | 249 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.78e-05 | 14 | 249 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.78e-05 | 14 | 249 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.78e-05 | 14 | 249 | 4 | PF08393 | |
| Domain | DHC_fam | 3.75e-05 | 15 | 249 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 3.75e-05 | 15 | 249 | 4 | PF03028 | |
| Domain | PI3/4_kinase_CS | 3.75e-05 | 15 | 249 | 4 | IPR018936 | |
| Domain | Dynein_heavy_dom | 3.75e-05 | 15 | 249 | 4 | IPR004273 | |
| Domain | Cyt_P450_E_CYP3A | 4.55e-05 | 6 | 249 | 3 | IPR008072 | |
| Domain | PI3Kc | 4.95e-05 | 16 | 249 | 4 | SM00146 | |
| Domain | - | 4.95e-05 | 16 | 249 | 4 | 1.10.1070.11 | |
| Domain | CarboxyPept-like_regulatory | 6.40e-05 | 17 | 249 | 4 | IPR008969 | |
| Domain | PI3/4_kinase_cat_dom | 8.15e-05 | 18 | 249 | 4 | IPR000403 | |
| Domain | PI3_PI4_kinase | 8.15e-05 | 18 | 249 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 8.15e-05 | 18 | 249 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.15e-05 | 18 | 249 | 4 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 8.15e-05 | 18 | 249 | 4 | PS50290 | |
| Domain | Carb-bd-like_fold | 1.25e-04 | 8 | 249 | 3 | IPR013784 | |
| Domain | DHC_N1 | 1.25e-04 | 8 | 249 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.25e-04 | 8 | 249 | 3 | IPR013594 | |
| Domain | Oligopep_transport | 1.77e-04 | 2 | 249 | 2 | IPR004768 | |
| Domain | RasGAP_C | 5.26e-04 | 3 | 249 | 2 | IPR000593 | |
| Domain | RasGAP_C | 5.26e-04 | 3 | 249 | 2 | PF03836 | |
| Domain | PTR2_1 | 5.26e-04 | 3 | 249 | 2 | PS01022 | |
| Domain | PTR2_symporter_CS | 5.26e-04 | 3 | 249 | 2 | IPR018456 | |
| Domain | CarboxyPept_regulatory_dom | 6.07e-04 | 13 | 249 | 3 | IPR014766 | |
| Domain | - | 6.07e-04 | 13 | 249 | 3 | 2.60.40.1120 | |
| Domain | PTR2_2 | 1.04e-03 | 4 | 249 | 2 | PS01023 | |
| Domain | CLASP_N | 1.04e-03 | 4 | 249 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 1.04e-03 | 4 | 249 | 2 | IPR024395 | |
| Pubmed | DDX19B HSP90B1 ERCC6L USP9X MATR3 PSMD1 CLASP2 FYCO1 F5 ACSL1 NCAPG PIK3C3 MKI67 PLD1 IPO5 NIBAN1 CLASP1 CAMK2D HEATR1 ECPAS CBFB YWHAB NOMO1 PAPOLG FADS1 CSE1L ERGIC3 MTOR HELZ2 EIF3A PRKDC NNT CNOT1 SLC33A1 | 7.06e-12 | 1168 | 253 | 34 | 19946888 | |
| Pubmed | DHX36 USP9X PSMD1 IQGAP1 SUPT6H MKI67 PUM3 UTRN DNMT1 IPO5 RANGAP1 SMCHD1 LMNB2 HEATR1 ECPAS CSE1L MTOR PHF3 HELZ2 PRKDC IK NNT CNOT1 RAI1 HDAC2 | 1.82e-11 | 653 | 253 | 25 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 HSP90B1 USP9X MATR3 PSMB5 PSMD1 CLASP2 IQGAP1 NCAPG SERPINB3 SUPT6H GLO1 MKI67 PUM3 DNAH5 DNMT1 VAT1 IPO5 RANGAP1 DNAH10 SMCHD1 LMNB2 HEATR1 ECPAS NOMO1 TFRC CSE1L MTOR SUPT16H UBA6 EIF3A PRKDC CACYBP IK NNT CNOT1 TOP2A | 2.09e-11 | 1425 | 253 | 37 | 30948266 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DDX19B DHX36 AKAP17A IQGAP2 ERCC6L USP9X MATR3 PSMB5 PSMD1 CLASP2 C2CD5 IQGAP1 NCAPG BRAF PIK3C3 SERPINB3 SERPINB4 PI4KB PIP5K1B HERC1 RANGAP1 CLASP1 CAMK2D COX5B HEATR1 ECPAS PAPSS2 YWHAB FADS1 LOXHD1 KMT5B EIF3A CACYBP CNOT1 | 8.88e-11 | 1284 | 253 | 34 | 17353931 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | DHX36 HSP90B1 USP9X PSMD1 IQGAP1 NCAPG NOMO2 GLO1 WDR1 IPO5 NOMO1 CSE1L SUPT16H HELZ2 EIF3A PRKDC NNT NOMO3 | 9.77e-11 | 344 | 253 | 18 | 30333137 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSP90B1 USP9X MATR3 PSMD1 F5 IQGAP1 SUPT6H GLO1 MKI67 PUM3 UTRN IPO5 NIBAN1 RANGAP1 SMCHD1 LMNB2 HEATR1 YWHAB TFRC CSE1L GET3 SUPT16H UBA6 EIF3A PRKDC IK NNT CNOT1 TOP2A HDAC2 | 1.16e-10 | 1024 | 253 | 30 | 24711643 |
| Pubmed | IQGAP2 ACADSB MATR3 PSMD1 IQGAP1 ACSL1 NCAPG NOMO2 SUPT6H SGPL1 WDR1 IPO5 RANGAP1 ECPAS PPP2R5A PPP2R5E CSE1L IK NNT CNOT1 TOP2A HDAC2 | 1.93e-10 | 560 | 253 | 22 | 35241646 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX19B HSP90B1 ACADSB PSMB5 PSMD1 CLASP2 IQGAP1 FBXO38 STK11 SUPT6H SERPINB4 PAN2 DLG1 POLR1B UTRN DNMT1 VAT1 IPO5 RANGAP1 USP28 CAMK2D YWHAB USP6 CSE1L GET3 SUPT16H EIF3A CACYBP CNOT1 | 3.44e-10 | 1005 | 253 | 29 | 19615732 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 HSP90B1 MATR3 PSMB5 PSMD1 IQGAP1 ACSL1 NCAPG SERPINB3 SERPINB4 SGPL1 MKI67 POLR1B PUM3 WDR1 UTRN DNMT1 RANGAP1 GNE CAMK2D SMCHD1 XPC LMNB2 HEATR1 PAPSS2 YWHAB TFRC CSE1L SUPT16H EIF3A PRKDC POLD3 IK TOP2A | 3.48e-10 | 1353 | 253 | 34 | 29467282 |
| Pubmed | HSP90B1 ERCC6L USP9X PSMD1 CLASP2 IQGAP1 NCAPG SUPT6H IPO5 RANGAP1 LMNB2 HEATR1 ECPAS NOMO1 TFRC CSE1L MTOR SUPT16H EIF3A PRKDC CACYBP CNOT1 HDAC2 | 3.92e-10 | 638 | 253 | 23 | 33239621 | |
| Pubmed | HSP90B1 IQGAP2 MATR3 NMRAL1 PSMD1 PLA2G4D LYST IQGAP1 STK11 EFCAB12 VPS13A DLG1 GPR171 ALCAM DNAH6 VAT1 RANGAP1 PCDHGA3 SMCHD1 COQ6 GRIA2 XPC LMNB2 HEATR1 YWHAB TFRC DGKK SUPT16H EIF3A ZNF84 PRKDC POTEJ TOP2A RAI1 HDAC2 | 4.67e-10 | 1442 | 253 | 35 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 HSP90B1 MATR3 PSMB5 F5 IQGAP1 SERPINB3 SGPL1 MKI67 DLG1 POLR1B PUM3 WDR1 DNMT1 CAMK2D SMCHD1 LMNB2 HEATR1 YWHAB PHC2 GSTM2 CSE1L MRPL15 PHF3 SUPT16H HELZ2 EIF3A PRKDC CACYBP IK TOP2A DMTN | 8.83e-10 | 1257 | 253 | 32 | 36526897 |
| Pubmed | USP9X MATR3 PSMB5 PSMD1 NCAPG SGPL1 POLR1B AK4 WDR1 GNE CAMK2D COX5B SMCHD1 YWHAB EIF3A PRKDC POLD3 NNT CNOT1 NOMO3 | 3.01e-09 | 534 | 253 | 20 | 35032548 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX19B DHX36 HSP90B1 IQGAP2 ACADSB USP9X MATR3 PSMB5 PSMD1 ACSL1 NOMO2 POLR1B DNA2 VAT1 IPO5 RANGAP1 CAMK2D MRPL13 YWHAB NOMO1 TFRC PTOV1 IGBP1 CSE1L ERGIC3 PRKDC POLD3 IK CNOT1 NOMO3 HDAC2 | 3.50e-09 | 1257 | 253 | 31 | 37317656 |
| Pubmed | HSP90B1 IQGAP2 FYCO1 IQGAP1 STK11 PIK3C3 PI4KB UTRN IPO5 ECPAS YWHAB PTOV1 MTOR SUPT16H EIF3A PRKDC CACYBP KLHDC10 | 4.39e-09 | 437 | 253 | 18 | 20562859 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | HSP90B1 NCAPG UTRN IPO5 RANGAP1 CAMK2D SMCHD1 XPC YWHAB PHC2 CSE1L SUPT16H PRKDC CNOT1 TOP2A RAI1 HDAC2 | 6.02e-09 | 394 | 253 | 17 | 27248496 |
| Pubmed | BCL9L USP9X CLASP2 C2CD5 BRAF SGPL1 PI4KB UTRN CLASP1 ECPAS YWHAB ANKRD44 IGBP1 TRAPPC3 PRKDC CACYBP CNOT1 DMTN | 6.02e-09 | 446 | 253 | 18 | 24255178 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATP6V1E1 USP9X PSMB5 IQGAP1 NCAPG SERPINB13 SERPINB3 DLG1 ALCAM WDR1 UTRN GNS DNMT1 VAT1 RANGAP1 CLASP1 CAMK2D ECPAS YWHAB TFRC IGBP1 MTOR GET3 SUPT16H UBA6 EIF3A TRAPPC3 PRKDC CACYBP NNT CNOT1 TOP2A | 6.64e-09 | 1367 | 253 | 32 | 32687490 |
| Pubmed | MATR3 PSMB5 IQGAP1 NCAPG SUPT6H MKI67 WDR1 DNMT1 IPO5 USP28 SMCHD1 LMNB2 ECPAS CBFB PHC2 TFRC CSE1L PHF3 SUPT16H UBA6 EIF3A PRKDC POLD3 CACYBP IK TOP2A HDAC2 | 7.97e-09 | 1014 | 253 | 27 | 32416067 | |
| Pubmed | DDX19B DHX36 HSP90B1 ATP6V1E1 ACADSB MATR3 PSMB5 PSMD1 CLASP2 IQGAP1 BRAF TULP4 MKI67 DLG1 WDR1 IPO5 RANGAP1 CAMK2D CBFB YWHAB IGBP1 CSE1L PHF3 GET3 PRKDC POLD3 CACYBP IK TOP2A HDAC2 | 1.12e-08 | 1247 | 253 | 30 | 27684187 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ATP6V1E1 IQGAP2 USP9X PSMB5 PSMD1 C2CD5 SGPL1 ABCG2 UTRN VPS39 CAMK2D TFRC IK DEPDC1B HDAC2 | 1.20e-08 | 313 | 253 | 15 | 38270169 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | DHX36 CLASP2 IQGAP1 NCAPG NIBAN1 CAMK2D SMCHD1 HEATR1 CBFB PHC2 PPP2R5A CSE1L PHF3 ELF4 IK HDAC2 | 1.65e-08 | 370 | 253 | 16 | 22922362 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HSP90B1 MATR3 PSMD1 PTGFRN PIAS3 SGPL1 MKI67 SLC39A6 ALCAM WDR1 VAT1 IPO5 RANGAP1 CLASP1 XPC LMNB2 HEATR1 TFRC FADS1 PPP2R5E CSE1L ERGIC3 PHF3 CENPI GHITM PRKDC NNT CNOT1 TOP2A | 1.92e-08 | 1203 | 253 | 29 | 29180619 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DHX36 HSP90B1 MATR3 IQGAP1 SERPINB3 SUPT6H MKI67 PUM3 DNMT1 USP28 SMCHD1 LMNB2 HEATR1 YWHAB PHC2 TFRC PAPOLG PTOV1 FADS1 PHF3 SUPT16H EIF3A PRKDC IK TOP2A HDAC2 | 1.98e-08 | 989 | 253 | 26 | 36424410 |
| Pubmed | ATP6V1E1 MATR3 F5 IQGAP1 MKI67 DLG1 POLR1B WDR1 RANGAP1 SMCHD1 LMNB2 HEATR1 YWHAB TFRC SUPT16H EIF3A PRKDC POTEJ IK TOP2A HDAC2 | 2.05e-08 | 660 | 253 | 21 | 32780723 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSP90B1 MATR3 PSMB5 PSMD1 FYCO1 IQGAP1 GLO1 WDR1 UTRN VAT1 IPO5 COQ6 ECPAS PAPSS2 YWHAB EPG5 TFRC CSE1L EIF3A PRKDC CACYBP NNT CNOT1 | 3.21e-08 | 807 | 253 | 23 | 30575818 |
| Pubmed | IQGAP2 USP9X MATR3 CLASP2 FYCO1 HCN2 IQGAP1 DLG1 WDR1 DNMT1 RANGAP1 CLASP1 USP28 CAMK2D GRIA2 LMNB2 YWHAB MTOR SH3D19 SUPT16H UBA6 TRAPPC3 CNOT1 RAI1 HDAC2 | 4.81e-08 | 963 | 253 | 25 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MATR3 PSMB5 PSMD1 C2CD5 ACSL1 PTPN4 TXNDC16 DLG1 WDR1 UTRN IPO5 CLASP1 SMCHD1 HEATR1 ECPAS YWHAB NOMO1 TFRC PTOV1 CSE1L MTOR GHITM EIF3A PRKDC CACYBP | 5.97e-08 | 974 | 253 | 25 | 28675297 |
| Pubmed | DDX19B ERBB4 CYP3A5 PIPOX AK4 DMGDH CAMK2D LMNB2 ECPAS ACSM4 MTOR EIF3A NNT CNOT1 | 6.09e-08 | 304 | 253 | 14 | 32235678 | |
| Pubmed | HSP90B1 USP9X PSMD1 CLASP2 FBXO38 PTPN4 NCAPG VPS13A MKI67 SLC39A6 DLG1 HERC1 UTRN DNMT1 VAT1 RANGAP1 YWHAB IGBP1 PPP2R5A PPP2R5E CSE1L SUPT16H CACYBP IK SLC12A7 CNOT1 | 6.36e-08 | 1049 | 253 | 26 | 27880917 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ERCC6L MATR3 TATDN2 PSMD1 C2CD5 IQGAP1 FBXO38 BRAF MKI67 DLG1 PLCB3 DNMT1 RANGAP1 CLASP1 XPC ECPAS PHC2 PAPOLG PHF3 HELZ2 PRKDC TOP2A | 6.79e-08 | 774 | 253 | 22 | 15302935 |
| Pubmed | HSP90B1 IQGAP2 ACADSB PSMB5 PSMD1 PTGFRN IQGAP1 NCAPG SGPL1 MKI67 PUM3 WDR1 GNS IPO5 RANGAP1 HEATR1 ECPAS FHIP2A YWHAB TFRC FADS1 CSE1L MRPL15 MTOR SUPT16H EIF3A TRAPPC3 PRKDC CNOT1 VPS53 TOP2A | 7.72e-08 | 1440 | 253 | 31 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19B HSP90B1 ATP6V1E1 USP9X PSMB5 PSMD1 IQGAP1 NCAPG PLCB3 WDR1 HERC1 GNS VAT1 IPO5 NIBAN1 RANGAP1 GNE ECPAS PAPSS2 YWHAB PPP2R5E CSE1L MTOR GET3 SUPT16H UBA6 EIF3A PRKDC POLD3 CACYBP CNOT1 | 9.71e-08 | 1455 | 253 | 31 | 22863883 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DDX19B ATP6V1E1 IQGAP2 PSMB5 IRF6 IQGAP1 STK11 SERPINB13 SERPINB3 GLO1 ALCAM WDR1 UTRN SLC23A1 VAT1 AOX1 SLC5A9 GSTM2 ACE2 CSE1L SLC15A2 GET3 ATP6V0A4 GHITM LRP2 | 1.33e-07 | 1016 | 253 | 25 | 19056867 |
| Pubmed | USP9X PSMD1 PLCB3 ALCAM NIBAN1 GNE CLASP1 CAMK2D COX5B PAPSS2 PPP2R5E EIF3A NNT CNOT1 | 1.38e-07 | 325 | 253 | 14 | 36168628 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DHX36 HSP90B1 USP9X MATR3 PSMB5 PSMD1 CLASP2 IQGAP1 NCAPG SUPT6H PLCB3 DNMT1 IPO5 RANGAP1 CLASP1 SMCHD1 PAPSS2 YWHAB TFRC CSE1L SUPT16H UBA6 EIF3A TRAPPC3 PRKDC CACYBP IK KLHDC10 TOP2A HDAC2 | 1.77e-07 | 1415 | 253 | 30 | 28515276 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.87e-07 | 8 | 253 | 4 | 15257293 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | IQGAP2 PSMB5 MKI67 POLR1B NIBAN1 RANGAP1 COX5B PAPSS2 FADS1 CSE1L MTOR GET3 SUPT16H CACYBP TOP2A | 2.93e-07 | 400 | 253 | 15 | 35013556 |
| Pubmed | HSP90B1 PSMD1 IQGAP1 AK4 WDR1 ZPBP COX5B AOX1 PAPSS2 ACE2 CSE1L GET3 | 3.35e-07 | 249 | 253 | 12 | 30097533 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSP90B1 IQGAP2 USP9X MATR3 PSMD1 CLASP2 IQGAP1 GLO1 WDR1 VAT1 IPO5 RANGAP1 CAMK2D ECPAS YWHAB TFRC CSE1L GET3 SUPT16H EIF3A TRAPPC3 PRKDC POLD3 CACYBP CNOT1 HDAC2 | 3.67e-07 | 1149 | 253 | 26 | 35446349 |
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 3.80e-07 | 3 | 253 | 3 | 20615193 | |
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 32146629 | ||
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 21173574 | ||
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 17582393 | ||
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 36011023 | ||
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 19801957 | ||
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 20621111 | ||
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 20118548 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 3.80e-07 | 3 | 253 | 3 | 23143891 | |
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 33866277 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 3.80e-07 | 3 | 253 | 3 | 32001245 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 3.80e-07 | 3 | 253 | 3 | 25576386 | |
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 34688813 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | NMRAL1 PTGFRN C2CD5 NOMO2 SGPL1 DLG1 ALCAM PLD1 HERC1 UTRN FAM135A VPS39 MRPL13 ERGIC3 TENM3 SH3D19 CENPI GHITM SLC12A7 SLC33A1 | 3.84e-07 | 719 | 253 | 20 | 35337019 |
| Pubmed | DHX36 IFT140 MATR3 IQGAP1 TRANK1 SULF1 SUPT6H PAN2 DNA2 RANGAP1 VPS39 USP28 SMCHD1 KBTBD2 ECPAS CNOT1 RAI1 | 4.14e-07 | 529 | 253 | 17 | 14621295 | |
| Pubmed | IQGAP2 MATR3 PSMD1 CLASP2 ITGA9 C2CD5 STK11 BRAF SGPL1 PAN2 DLG1 PLD1 HERC1 DNA2 UTRN FAM135A VPS39 CAMK2D HEATR1 PPP2R5E LRP2 IK KLHDC10 CNOT1 SLC33A1 | 4.41e-07 | 1084 | 253 | 25 | 11544199 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | PSMB5 SUPT6H MKI67 DLG1 PUM3 PLD1 SMCHD1 MRPL13 YWHAB TENM3 MTOR SUPT16H CNOT1 TOP2A | 4.45e-07 | 358 | 253 | 14 | 32460013 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L MATR3 TOGARAM1 CLASP2 F5 SGPL1 EFCAB12 DNAH6 DNAH9 CLASP1 SMCHD1 PHF3 EIF3A PRKDC | 4.92e-07 | 361 | 253 | 14 | 26167880 |
| Pubmed | SELENOT HSP90B1 ACADSB CLASP2 C2CD5 NEO1 NCAPG NOMO2 SUPT6H VPS13A SLC39A6 DLG1 AK4 DNA2 FAM135A DNMT1 RANGAP1 COX5B MRPL13 LMNB2 HEATR1 NOMO1 TFRC MRPL15 GHITM SUPT16H UBA6 CACYBP SLC33A1 DEPDC1B | 5.01e-07 | 1487 | 253 | 30 | 33957083 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP6V1E1 IQGAP2 USP9X MATR3 IQGAP1 SGPL1 DNMT1 IPO5 RANGAP1 SMCHD1 COQ6 YWHAB TFRC CSE1L SUPT16H EIF3A CACYBP CNOT1 TOP2A | 5.08e-07 | 665 | 253 | 19 | 30457570 |
| Pubmed | DDX19B DHX36 IQGAP2 ACADSB NOMO2 VPS13A POLR1B DNA2 VAT1 CAMK2D COX5B HEATR1 NOMO1 IGBP1 MTOR POLD3 VPS53 NOMO3 | 5.87e-07 | 606 | 253 | 18 | 36538041 | |
| Pubmed | ERCC6L USP9X MATR3 NCAPG DLG1 DNMT1 RANGAP1 SMCHD1 HEATR1 PHF3 SH3D19 PRKDC CACYBP IK CNOT1 TOP2A HDAC2 | 6.90e-07 | 549 | 253 | 17 | 38280479 | |
| Pubmed | HSP90B1 MATR3 PSMB5 PSMD1 IQGAP1 MKI67 SLC39A6 IPO5 RANGAP1 CAMK2D ECPAS TFRC CSE1L SUPT16H EIF3A CNOT1 | 8.23e-07 | 494 | 253 | 16 | 26831064 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | USP9X MATR3 PSMD1 IQGAP1 SERPINB3 IPO5 TFRC CSE1L EIF3A PRKDC | 8.54e-07 | 179 | 253 | 10 | 36261009 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 AKAP17A IQGAP2 MATR3 IQGAP1 PIK3C3 MKI67 POLR1B PUM3 DNMT1 CLASP1 SMCHD1 HEATR1 CSE1L PHF3 SUPT16H PRKDC IK CNOT1 TOP2A | 8.90e-07 | 759 | 253 | 20 | 35915203 |
| Pubmed | HSP90B1 AKAP17A USP9X MCF2L2 PSMD1 ZNF302 RYR3 IQGAP1 FOCAD PIAS3 NOMO2 SULF1 DLG1 UTRN DNMT1 IPO5 VPS39 USP28 XPC REV3L CBFB YWHAB PPP2R5E SH3D19 LRP2 ZNF84 PRKDC | 9.05e-07 | 1285 | 253 | 27 | 35914814 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ACADSB USP9X TLCD4 CLASP2 ELOVL7 FOCAD DOCK5 NEO1 GLO1 VPS13A DLG1 AK4 HERC1 CLASP1 VPS39 LMCD1 SMCHD1 LDAF1 COQ6 PCDHA12 PRKDC POLD3 SLC12A7 SLC33A1 | 1.07e-06 | 1061 | 253 | 24 | 33845483 |
| Pubmed | SELENOT ERBB4 USP9X MATR3 PIK3C3 SUPT6H VPS13A PCDH11X HERC1 LDAF1 ECPAS PTOV1 FADS1 GHITM TRAPPC3 IK LY9 | 1.10e-06 | 568 | 253 | 17 | 9110174 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | IQGAP2 ERCC6L DOCK5 NEO1 BRAF PCDH11X DLG1 PLCB3 ALCAM FAM135A VAT1 TFRC ACE2 SLC15A1 MTOR SLC12A7 DEPDC1B | 1.12e-06 | 569 | 253 | 17 | 30639242 |
| Pubmed | DDX19B ACADSB ERCC6L LRRC37A3 USP9X CSMD2 PI4KB VPS13A TBX4 COX5B XPC REV3L USP6 PRELP POTEJ CNOT1 NOMO3 RAI1 | 1.22e-06 | 638 | 253 | 18 | 31182584 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | SELENOT ERBB4 USP9X MATR3 PIK3C3 SUPT6H VPS13A PCDH11X HERC1 LDAF1 ECPAS PTOV1 FADS1 GHITM TRAPPC3 IK LY9 | 1.27e-06 | 574 | 253 | 17 | 8619474 |
| Pubmed | HSP90B1 ERCC6L USP9X PSMD1 THSD1 IQGAP1 DLG1 FAM135A IPO5 RANGAP1 ECPAS TFRC CSE1L SH3D19 UBA6 PRKDC CACYBP CNOT1 DEPDC1B | 1.29e-06 | 708 | 253 | 19 | 39231216 | |
| Pubmed | 1.32e-06 | 108 | 253 | 8 | 19956635 | ||
| Pubmed | 1.42e-06 | 147 | 253 | 9 | 29576527 | ||
| Pubmed | Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. | 1.51e-06 | 4 | 253 | 3 | 18309947 | |
| Pubmed | Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. | 1.51e-06 | 4 | 253 | 3 | 22024166 | |
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 11175280 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.51e-06 | 4 | 253 | 3 | 31833031 | |
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 9267806 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 37420302 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 34689350 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 22419166 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 18978522 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | HSP90B1 USP9X TATDN2 LYST AWAT1 PI4KB VPS13A SLC39A6 VPS39 HEATR1 TFRC GET3 PRKDC VPS53 SLC33A1 | 1.55e-06 | 457 | 253 | 15 | 32968282 |
| Pubmed | DHX36 ATP6V1E1 CYP3A5 USP9X MATR3 CLASP2 C2CD5 ACSL1 SERPINB3 SERPINB4 SGPL1 PUM3 SLC23A1 IPO5 VPS39 HEATR1 PAPSS2 PAPOLG IGBP1 PPP2R5E SLC15A2 KMT5B CENPI SUPT16H TRAPPC3 CNOT1 SLC33A1 | 1.66e-06 | 1327 | 253 | 27 | 32694731 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DDX19B DHX36 HSP90B1 ACADSB MATR3 PSMB5 PSMD1 GLO1 VPS13A AK4 HERC1 VAT1 IPO5 COX5B MRPL13 LMNB2 HEATR1 YWHAB MRPL15 SH3D19 MTRFR GHITM SUPT16H LRP2 CACYBP NNT SLC33A1 DEPDC1B TOP2A | 1.75e-06 | 1496 | 253 | 29 | 32877691 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ERCC6L USP9X PSMD1 PTGFRN IQGAP1 NCAPG DNMT1 RANGAP1 CAMK2D LMNB2 HEATR1 ECPAS TFRC FADS1 PPP2R5E CSE1L MTOR TRAPPC3 PRKDC VPS53 SLC33A1 NOMO3 | 1.83e-06 | 942 | 253 | 22 | 31073040 |
| Pubmed | HSP90B1 USP9X PSMD1 VPS13A IPO5 RANGAP1 HEATR1 ECPAS NOMO1 TFRC CSE1L ERGIC3 MTOR GET3 EIF3A PRKDC CACYBP CNOT1 | 1.85e-06 | 657 | 253 | 18 | 36180527 | |
| Pubmed | HSP90B1 USP9X MATR3 PSMD1 VPS13A IPO5 RANGAP1 HEATR1 ECPAS TFRC CSE1L EIF3A PRKDC CNOT1 | 2.08e-06 | 408 | 253 | 14 | 33766124 | |
| Pubmed | DHX36 BCL9L USP9X MATR3 PSMB5 PSMD1 GLO1 MKI67 PUM3 WDR1 HERC1 SENP5 DNAH10 COX5B SMCHD1 MRPL13 SLC5A9 TFRC CSE1L MRPL15 DGKK LRP2 ELF4 EIF3A TRAPPC3 CACYBP CNOT1 HDAC2 | 2.17e-06 | 1429 | 253 | 28 | 35140242 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | DHX36 HSP90B1 RMI1 SERPINB4 MKI67 PUM3 UTRN IPO5 VPS39 XPC LMNB2 IK VPS53 HDAC2 | 2.20e-06 | 410 | 253 | 14 | 26949251 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | IQGAP1 DOCK5 DNMT1 IPO5 SMCHD1 ECPAS MTOR SUPT16H PRKDC CNOT1 | 2.55e-06 | 202 | 253 | 10 | 33005030 |
| Pubmed | 2.58e-06 | 14 | 253 | 4 | 9373155 | ||
| Pubmed | HSP90B1 ATP6V1E1 USP9X IQGAP1 STK11 NCAPG ALCAM IPO5 SMCHD1 HEATR1 YWHAB TFRC CACYBP CNOT1 TOP2A | 3.12e-06 | 484 | 253 | 15 | 31995728 | |
| Pubmed | 3.76e-06 | 5 | 253 | 3 | 24168324 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 3.76e-06 | 5 | 253 | 3 | 11266076 | |
| Pubmed | Population pharmacokinetics and pharmacogenetics of imatinib in children and adults. | 3.76e-06 | 5 | 253 | 3 | 18981009 | |
| Pubmed | ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry. | 3.76e-06 | 5 | 253 | 3 | 23849778 | |
| Pubmed | 3.76e-06 | 5 | 253 | 3 | 12969965 | ||
| Pubmed | 3.76e-06 | 5 | 253 | 3 | 11093772 | ||
| Interaction | SIRT7 interactions | DHX36 USP9X PSMD1 IQGAP1 SUPT6H MKI67 PUM3 UTRN DNMT1 IPO5 RANGAP1 SMCHD1 LMNB2 HEATR1 ECPAS CSE1L MTOR PHF3 HELZ2 PRKDC IK NNT CNOT1 TOP2A RAI1 HDAC2 | 1.81e-06 | 744 | 248 | 26 | int:SIRT7 |
| Interaction | C9orf78 interactions | IQGAP2 ACADSB MATR3 PSMD1 IQGAP1 ACSL1 NCAPG SERPINB13 NOMO2 SUPT6H SGPL1 WDR1 IPO5 RANGAP1 ECPAS PPP2R5A PPP2R5E CSE1L IK NNT CNOT1 TOP2A HDAC2 | 2.76e-06 | 620 | 248 | 23 | int:C9orf78 |
| Interaction | GPR182 interactions | DDX19B TLCD4 FOCAD DOCK5 ACSL1 SGPL1 SLC39A6 COQ6 HEATR1 ECPAS NOMO1 FADS1 CSE1L ERGIC3 MTOR PRKDC POLD3 VPS53 SLC33A1 | 3.95e-06 | 455 | 248 | 19 | int:GPR182 |
| Interaction | SUMO2 interactions | HSP90B1 USP9X IQGAP1 FBXO38 NCAPG PIAS3 MKI67 DNMT1 SENP5 IPO5 RANGAP1 USP28 SMCHD1 YWHAB ACE2 IGBP1 CSE1L PHF3 SUPT16H PRKDC TOP2A HDAC2 | 4.34e-06 | 591 | 248 | 22 | int:SUMO2 |
| Interaction | RHOBTB2 interactions | USP9X PSMD1 STK11 NCAPG WDR1 FADS1 CSE1L SUPT16H POTEJ CACYBP DEPDC1B | 6.53e-06 | 165 | 248 | 11 | int:RHOBTB2 |
| Interaction | ITGB3 interactions | HSP90B1 USP9X PSMD1 IQGAP1 NCAPG IPO5 GRIA2 CSE1L EIF3A PRKDC NNT | 8.68e-06 | 170 | 248 | 11 | int:ITGB3 |
| Interaction | CYP3A5 interactions | 1.03e-05 | 12 | 248 | 4 | int:CYP3A5 | |
| Interaction | RHOV interactions | USP9X PSMD1 IQGAP1 SLC39A6 DLG1 WDR1 IPO5 TFRC FADS1 CSE1L MTOR SLC12A7 DEPDC1B | 1.06e-05 | 243 | 248 | 13 | int:RHOV |
| Interaction | BRAF interactions | HSP90B1 IQGAP1 STK11 BRAF NOMO2 SGPL1 USP28 ECPAS YWHAB NOMO1 NOMO3 HDAC2 | 1.32e-05 | 212 | 248 | 12 | int:BRAF |
| Interaction | CUL7 interactions | HSP90B1 MATR3 IQGAP1 STK11 PIK3C3 SUPT6H GLO1 MKI67 PLCB3 WDR1 IPO5 RANGAP1 PCDHGA3 SMCHD1 MRPL13 LMNB2 HEATR1 YWHAB TFRC GET3 SUPT16H PRKDC IK NNT TOP2A HDAC2 | 1.74e-05 | 845 | 248 | 26 | int:CUL7 |
| Interaction | BIRC3 interactions | DHX36 HSP90B1 USP9X MATR3 PSMB5 PSMD1 IQGAP1 NCAPG SERPINB3 SUPT6H GLO1 MKI67 WDR1 DNAH5 DNMT1 VAT1 IPO5 RANGAP1 DNAH10 SMCHD1 LMNB2 HEATR1 NOMO1 TFRC CSE1L MTOR SUPT16H UBA6 EIF3A PRKDC CACYBP IK NNT CNOT1 TOP2A | 1.82e-05 | 1334 | 248 | 35 | int:BIRC3 |
| Interaction | DIRAS3 interactions | PSMD1 PIK3C3 SLC39A6 DLG1 ALCAM HERC1 FAM135A IPO5 ECPAS TFRC CACYBP SLC12A7 DEPDC1B | 2.35e-05 | 262 | 248 | 13 | int:DIRAS3 |
| Interaction | RHOF interactions | DDX19B USP9X C2CD5 IQGAP1 NCAPG VPS13A SLC39A6 DLG1 PLCB3 UTRN FAM135A LMNB2 ECPAS TFRC FADS1 CSE1L MTOR SUPT16H PRKDC SLC12A7 SLC33A1 DEPDC1B | 3.25e-05 | 673 | 248 | 22 | int:RHOF |
| Interaction | CCDC8 interactions | HSP90B1 USP9X MATR3 PSMD1 F5 IQGAP1 MKI67 UTRN NIBAN1 SMCHD1 MROH2A LMNB2 HEATR1 CSE1L UBA6 EIF3A PRKDC NNT CNOT1 TOP2A HDAC2 | 6.64e-05 | 656 | 248 | 21 | int:CCDC8 |
| Interaction | BRCA1 interactions | HSP90B1 USP9X MATR3 PSMB5 TATDN2 PSMD1 IQGAP1 FBXO38 RMI1 SUPT6H MKI67 SLC39A6 HERC1 DNMT1 VDR IPO5 RANGAP1 USP28 CAMK2D SMCHD1 ECPAS TFRC ANKRD44 CSE1L MTOR CENPI SUPT16H EIF3A PRKDC CNOT1 TOP2A HDAC2 | 6.78e-05 | 1249 | 248 | 32 | int:BRCA1 |
| Interaction | KCNA3 interactions | HSP90B1 ERCC6L USP9X PSMD1 FYCO1 THSD1 IQGAP1 VPS13A DLG1 DNAH5 FAM135A IPO5 RANGAP1 ECPAS TFRC PAPOLG CSE1L PHF3 SH3D19 UBA6 LRP2 PRKDC CACYBP CNOT1 DEPDC1B | 7.84e-05 | 871 | 248 | 25 | int:KCNA3 |
| Interaction | TEX101 interactions | HSP90B1 PSMD1 IQGAP1 AK4 WDR1 ZPBP COX5B AOX1 PAPSS2 ACE2 CSE1L GET3 | 8.05e-05 | 255 | 248 | 12 | int:TEX101 |
| Interaction | WDR76 interactions | HSP90B1 TINAGL1 FREM2 MKI67 POLR1B UTRN RANGAP1 CAMK2D SMCHD1 XPC YWHAB CSE1L SUPT16H PRKDC CNOT1 | 8.62e-05 | 383 | 248 | 15 | int:WDR76 |
| Interaction | GPR45 interactions | DDX19B ACSL1 SGPL1 SLC39A6 HEATR1 ODAD2 ECPAS FHIP2A NOMO1 CSE1L ERGIC3 MTOR SLC33A1 | 9.41e-05 | 300 | 248 | 13 | int:GPR45 |
| Interaction | FOXP3 interactions | DHX36 CLASP2 IQGAP1 NCAPG NIBAN1 CAMK2D SMCHD1 HEATR1 CBFB PHC2 PPP2R5A CSE1L PHF3 ELF4 IK HDAC2 | 9.65e-05 | 432 | 248 | 16 | int:FOXP3 |
| Interaction | NUPR1 interactions | ATP6V1E1 MATR3 F5 IQGAP1 MKI67 DLG1 POLR1B WDR1 RANGAP1 SMCHD1 LMNB2 HEATR1 YWHAB TFRC SUPT16H EIF3A PRKDC POTEJ IK TOP2A HDAC2 | 1.17e-04 | 683 | 248 | 21 | int:NUPR1 |
| Interaction | RHOJ interactions | IQGAP2 USP9X PSMD1 C2CD5 IQGAP1 NEO1 VPS13A SLC39A6 DLG1 UTRN FAM135A LMNB2 YWHAB TFRC FADS1 CSE1L MTOR SUPT16H SLC12A7 DEPDC1B | 1.18e-04 | 633 | 248 | 20 | int:RHOJ |
| GeneFamily | Dyneins, axonemal | 3.91e-07 | 17 | 170 | 5 | 536 | |
| GeneFamily | Cytochrome P450 family 3 | 4.42e-05 | 8 | 170 | 3 | 1002 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ATP6V1E1 AKAP17A IQGAP2 USP9X MATR3 PSMB5 PSMD1 ZNF302 MAGEF1 ACSL1 STK11 PIK3C3 GLO1 PIP5K1B WDR1 GNS IPO5 RANGAP1 XPC CBFB NOMO1 TFRC PTOV1 PPP2R5A FADS1 PPP2R5E ERGIC3 GET3 GHITM SUPT16H ELF4 EIF3A TRAPPC3 PRKDC CACYBP IL1B NNT HDAC2 | 5.78e-09 | 1399 | 250 | 38 | M535 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | ERCC6L AVL9 IQGAP1 NCAPG MKI67 IPO5 HEATR1 CBFB CSE1L SUPT16H EIF3A PRKDC POLD3 CNOT1 TOP2A | 2.05e-08 | 250 | 250 | 15 | M11318 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | AVL9 USP9X TOGARAM1 CLASP2 GCNT1 C2CD5 PTPN4 PIK3C3 VPS13A DLG1 PUM3 ALCAM GNE CLASP1 SMCHD1 REV3L CBFB USP6 PPP2R5A PPP2R5E CSE1L PHF3 EIF3A KLHDC10 TOP2A | 7.91e-07 | 856 | 250 | 25 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | TOGARAM1 PIK3C3 VPS13A MKI67 SH2B3 GNE CLASP1 REV3L KBTBD2 PHC2 USP6 PHF3 POLD3 TOP2A | 1.29e-06 | 300 | 250 | 14 | M8702 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | TOGARAM1 PIK3C3 MKI67 GNE CLASP1 REV3L USP6 PHF3 POLD3 TOP2A | 1.39e-06 | 145 | 250 | 10 | M1810 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATP6V1E1 USP9X MATR3 PIPOX PSMD1 TOGARAM1 ANO5 CLASP2 LYST C2CD5 NEO1 SERPINB4 PAN2 ALCAM DNAH5 UTRN FAM135A CACNA1D XPC ECPAS PAPSS2 PHC2 IGBP1 GHITM CACYBP KLHDC10 | 1.46e-06 | 946 | 250 | 26 | M39169 |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_UP | FYCO1 GCNT1 IQGAP1 PIAS3 TXNDC16 DNA2 UTRN NIBAN1 SMCHD1 FHIP2A EIF3A | 3.62e-06 | 199 | 250 | 11 | M4650 |
| Coexpression | GSE15215_CD2_POS_VS_NEG_PDC_DN | SELENOT PAN2 DLG1 VPS39 COQ6 LMNB2 TFRC IGBP1 PPP2R5A ERGIC3 MRPL15 | 3.80e-06 | 200 | 250 | 11 | M3521 |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 2.02e-05 | 196 | 250 | 10 | M7664 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN | PSMD1 FOCAD RMI1 DNA2 VDR RANGAP1 TFRC MRPL15 SUPT16H CACYBP | 2.30e-05 | 199 | 250 | 10 | M4523 |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN | 2.30e-05 | 199 | 250 | 10 | M9943 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | F5 ACSL1 TXNDC16 SPEF1 GNE AOX1 PAPSS2 SLC15A2 PRKDC SLC12A7 | 2.40e-05 | 200 | 250 | 10 | M7251 |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN | SELENOT ATP6V1E1 AVL9 USP9X FBXO38 DLG1 KBTBD2 CBFB PAPOLG SUPT16H | 2.40e-05 | 200 | 250 | 10 | M9049 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | PSMB5 FOCAD NCAPG MKI67 AK4 DNMT1 IPO5 HEATR1 ECPAS TFRC CSE1L ERGIC3 MRPL15 CENPI SUPT16H PRKDC TOP2A HDAC2 | 2.67e-05 | 612 | 250 | 18 | M4772 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | DHX36 CYP3A5 MATR3 NMRAL1 MKI67 POLR1B DNMT1 MRPL13 CBFB PAPSS2 PPP2R5E PRELP CENPI EIF3A NNT TOP2A HDAC2 | 2.70e-05 | 555 | 250 | 17 | M2343 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SELENOT IL10RA USP9X MATR3 LYST IQGAP1 PTPN4 TRANK1 GLO1 GPR171 WDR1 HERC1 UTRN DNMT1 NIBAN1 SH2B3 SMCHD1 REV3L KBTBD2 CBFB FHIP2A YWHAB EPG5 PAPOLG ANKRD44 PPP2R5E PHF3 CACYBP IK LY9 CNOT1 | 3.98e-05 | 1492 | 250 | 31 | M40023 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | NCAPG SULF1 SLC39A6 DNA2 IPO5 CLASP1 PAPSS2 TFRC ZNF84 PRKDC DEPDC1B TOP2A | 4.04e-05 | 305 | 250 | 12 | M19875 |
| Coexpression | GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP | 4.12e-05 | 171 | 250 | 9 | M368 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_DN | IQGAP1 NOMO2 DLG1 POLR1B WDR1 RANGAP1 KBTBD2 NOMO1 CACYBP NOMO3 | 4.80e-05 | 217 | 250 | 10 | MM778 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | TLCD4 MATR3 NCAPG MKI67 AK4 DNMT1 MRPL13 LMNB2 HEATR1 KBTBD2 CBFB TFRC CSE1L SUPT16H UBA6 PRKDC CACYBP NNT | 5.17e-05 | 644 | 250 | 18 | M10501 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | SELENOT ATP6V1E1 USP9X MATR3 PSMB5 PSMD1 CLASP2 GLO1 PCDH11X PIP5K1B HERC1 IPO5 COX5B MRPL13 GRIA2 YWHAB TFRC USP6 PPP2R5E CASD1 CSE1L MRPL15 GET3 GHITM CACYBP NNT DMTN | 6.63e-05 | 1248 | 250 | 27 | M17728 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | RMI1 FREM2 NCAPG SULF1 MKI67 SLC39A6 DNA2 DNMT1 CENPI POLD3 DEPDC1B TOP2A | 7.00e-05 | 323 | 250 | 12 | M2156 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | DHX36 MATR3 IQGAP1 FBXO38 SUPT6H DLG1 PUM3 AK4 DNMT1 SENP5 MRPL13 CBFB TFRC CSE1L SUPT16H UBA6 ELF4 CNOT1 TOP2A | 7.00e-05 | 721 | 250 | 19 | M10237 |
| Coexpression | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN | 7.55e-05 | 46 | 250 | 5 | M6792 | |
| Coexpression | GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN | 8.32e-05 | 146 | 250 | 8 | M452 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | PTPN4 PIAS3 PI4KB PLCB3 XPC YWHAB FADS1 SLC15A2 KMT5B CENPI GHITM TRAPPC3 | 9.88e-05 | 335 | 250 | 12 | M10277 |
| Coexpression | WONG_EMBRYONIC_STEM_CELL_CORE | ERCC6L PSMB5 PIPOX GLO1 AK4 DNMT1 COX5B MRPL13 CSE1L MRPL15 EIF3A TOP2A | 9.88e-05 | 335 | 250 | 12 | M7079 |
| Coexpression | GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | 1.22e-04 | 197 | 250 | 9 | M8170 | |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_UP | 1.22e-04 | 197 | 250 | 9 | M3166 | |
| Coexpression | GSE25087_FETAL_VS_ADULT_TREG_UP | 1.27e-04 | 198 | 250 | 9 | M4641 | |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_UP | 1.27e-04 | 198 | 250 | 9 | M5491 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | NEO1 SUPT6H SGPL1 ALCAM GNS SENP5 NIBAN1 COX5B TFRC CRYBB2 PHF3 ELF4 SLC12A7 | 1.32e-04 | 399 | 250 | 13 | M40939 |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN | EFCAB11 GPR87 ALCAM DNA2 CACNA1D CASD1 CSE1L SLC15A1 KLHDC10 | 1.32e-04 | 199 | 250 | 9 | M5107 |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.32e-04 | 199 | 250 | 9 | M9124 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | EFCAB11 ACADSB ERCC6L SIDT1 CLASP2 MAGEF1 RMI1 SGPL1 PAN2 DNA2 IPO5 HEATR1 TFRC PAPOLG PPP2R5A FADS1 CSE1L CENPI IK CNOT1 DEPDC1B TOP2A HDAC2 | 1.35e-04 | 1023 | 250 | 23 | M17122 |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN | 1.37e-04 | 200 | 250 | 9 | M9606 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 1.37e-04 | 200 | 250 | 9 | M7505 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN | 1.37e-04 | 200 | 250 | 9 | M3895 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP | 1.37e-04 | 200 | 250 | 9 | M9286 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP | 1.37e-04 | 200 | 250 | 9 | M9284 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 1.65e-04 | 85 | 250 | 6 | MM684 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_21_PRECICTIVE_ICB_RESISTANCE | 1.71e-04 | 206 | 250 | 9 | MM17087 | |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | DHX36 CYP3A5 IRF6 IQGAP1 FOCAD RMI1 MSANTD3 CPQ PUM3 DNMT1 MRPL13 HEATR1 FHIP2A IGBP1 PPP2R5A PHF3 SH3D19 MTRFR UBA6 IK SLC33A1 HDAC2 | 1.72e-04 | 972 | 250 | 22 | M15709 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | DHX36 HSP90B1 EFCAB11 ERCC6L MATR3 C2CD5 IQGAP1 PAN2 DNMT1 VAT1 RANGAP1 MRPL13 XPC CENPI PRKDC POLD3 DEPDC1B TOP2A | 1.88e-04 | 714 | 250 | 18 | M1744 |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | IQGAP2 IQGAP1 MKI67 IPO5 TFRC CSE1L GET3 EIF3A PRKDC NNT TOP2A | 1.92e-04 | 307 | 250 | 11 | M19745 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | HSP90B1 ERCC6L IRF6 NCAPG SULF1 MKI67 PAN2 SLC39A6 POLR1B DNA2 IPO5 SH2B3 CLASP1 LMNB2 HEATR1 PAPSS2 TFRC CSE1L MTRFR CENPI ZNF84 PRKDC CACYBP NNT VPS53 DEPDC1B TOP2A HDAC2 | 1.98e-04 | 1407 | 250 | 28 | M14427 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DHX36 HSP90B1 ATP6V1E1 IQGAP2 USP9X ZNF302 RMI1 MKI67 SLC39A6 PUM3 IPO5 SMCHD1 REV3L PAPSS2 PHF3 EIF3A HDAC2 | 2.06e-04 | 656 | 250 | 17 | M18979 |
| Coexpression | TRAVAGLINI_LUNG_NEUTROPHIL_CELL | ACSL1 FGD4 HERC1 NIBAN1 COX5B SMCHD1 STEAP4 PHC2 ANKRD44 DNAH17 SUPT16H MX2 | 2.24e-04 | 366 | 250 | 12 | M41688 |
| Coexpression | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP | 2.68e-04 | 173 | 250 | 8 | M2480 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP | 2.70e-04 | 93 | 250 | 6 | M3889 | |
| Coexpression | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN | 2.78e-04 | 174 | 250 | 8 | M17193 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | PSMB5 MKI67 PUM3 AK4 ALCAM DNA2 DNMT1 IPO5 RANGAP1 PHC2 TFRC CSE1L GET3 CACYBP TOP2A | 2.84e-04 | 550 | 250 | 15 | M16189 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 2.89e-04 | 175 | 250 | 8 | M336 | |
| Coexpression | GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN | 2.89e-04 | 175 | 250 | 8 | M5660 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.01e-04 | 176 | 250 | 8 | M2981 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 3.12e-04 | 177 | 250 | 8 | M9401 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CHONDROCYTE_PROGENITORS | 3.15e-04 | 62 | 250 | 5 | MM3645 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 3.37e-04 | 179 | 250 | 8 | M39308 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL | ERBB4 SIDT1 ACSL1 MKI67 PUM3 AK4 ALCAM PAPSS2 ACE2 CASD1 TOP2A | 3.46e-04 | 329 | 250 | 11 | M2631 |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 3.58e-04 | 15 | 250 | 3 | M1141 | |
| Coexpression | EPPERT_PROGENITOR | 3.71e-04 | 138 | 250 | 7 | M19232 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | TATDN2 MKI67 PUM3 DNA2 DNMT1 IPO5 LMNB2 CBFB YWHAB TFRC FADS1 PPP2R5E CSE1L CENPI PRKDC CNOT1 TOP2A HDAC2 | 4.03e-04 | 761 | 250 | 18 | M11961 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | PSMB5 MKI67 PUM3 AK4 ALCAM DNA2 DNMT1 IPO5 RANGAP1 PHC2 TFRC CSE1L GET3 CACYBP TOP2A | 4.20e-04 | 571 | 250 | 15 | MM1100 |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL | HSP90B1 ATP6V1E1 PSMB5 PSMD1 NCAPG GLO1 MKI67 ABCG2 ALCAM DNMT1 VAT1 MRPL13 YWHAB CSE1L GET3 POLD3 CACYBP IL1B HCK TOP2A HDAC2 | 4.24e-04 | 968 | 250 | 21 | M41693 |
| Coexpression | FISCHER_DREAM_TARGETS | ERCC6L RMI1 NCAPG MKI67 DNA2 DNMT1 RANGAP1 USP28 SMCHD1 HEATR1 CSE1L MTRFR SUPT16H EIF3A PRKDC POLD3 CACYBP CNOT1 DEPDC1B TOP2A TCTN2 | 4.30e-04 | 969 | 250 | 21 | M149 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | HSP90B1 PSMB5 NMRAL1 NOMO2 PI4KB DLG1 USP28 NOMO1 PRKDC KLHDC10 NNT CNOT1 SLC33A1 RAI1 TCTN2 | 4.36e-04 | 573 | 250 | 15 | M41006 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 4.51e-04 | 187 | 250 | 8 | M6807 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ERCC6L NMRAL1 DOCK5 NCAPG MKI67 AK4 DNA2 DNMT1 RANGAP1 LMNB2 PTOV1 CENPI POLD3 DEPDC1B TOP2A | 4.77e-04 | 578 | 250 | 15 | M2368 |
| Coexpression | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN | 4.80e-04 | 237 | 250 | 9 | M8897 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | ERCC6L NCAPG MKI67 AK4 DNA2 IPO5 MRPL13 CSE1L CENPI UBA6 PRKDC TOP2A HDAC2 | 4.95e-04 | 458 | 250 | 13 | M8520 |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | HSP90B1 PSMB5 MAGEF1 NCAPG PIAS3 SGPL1 SLC39A6 POLR1B HERC1 GNS IPO5 PTOV1 IGBP1 MTOR SUPT16H TRAPPC3 PRKDC CACYBP | 4.99e-04 | 775 | 250 | 18 | M17753 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 5.01e-04 | 190 | 250 | 8 | M761 | |
| Coexpression | CYCLIN_D1_UP.V1_DN | 5.01e-04 | 190 | 250 | 8 | M2652 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 5.18e-04 | 69 | 250 | 5 | M1609 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 5.46e-04 | 106 | 250 | 6 | MM1265 | |
| Coexpression | DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 5.58e-04 | 242 | 250 | 9 | M34034 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 5.74e-04 | 107 | 250 | 6 | M39165 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | USP9X CLASP2 C2CD5 PIK3C3 VPS13A PUM3 CLASP1 SMCHD1 REV3L USP6 PPP2R5E PHF3 TOP2A | 5.81e-04 | 466 | 250 | 13 | M13522 |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN | 5.94e-04 | 195 | 250 | 8 | M7287 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 6.15e-04 | 196 | 250 | 8 | M4928 | |
| Coexpression | CHESLER_BRAIN_HIGHEST_EXPRESSION | 6.20e-04 | 41 | 250 | 4 | MM618 | |
| Coexpression | CHESLER_BRAIN_HIGHEST_EXPRESSION | 6.20e-04 | 41 | 250 | 4 | M4519 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN | 6.36e-04 | 197 | 250 | 8 | M8561 | |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_DN | 6.36e-04 | 197 | 250 | 8 | M5433 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN | 6.57e-04 | 198 | 250 | 8 | M5171 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ERCC6L NMRAL1 DOCK5 NCAPG MKI67 AK4 DNA2 DNMT1 RANGAP1 LMNB2 PTOV1 CENPI POLD3 DEPDC1B TOP2A | 6.64e-04 | 597 | 250 | 15 | MM1309 |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 6.79e-04 | 199 | 250 | 8 | M4607 | |
| Coexpression | GSE14308_TH1_VS_NATURAL_TREG_DN | 6.79e-04 | 199 | 250 | 8 | M3381 | |
| Coexpression | GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 6.79e-04 | 199 | 250 | 8 | M8418 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_UP | 6.79e-04 | 199 | 250 | 8 | M4749 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP | 6.79e-04 | 199 | 250 | 8 | M8429 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP | 6.79e-04 | 199 | 250 | 8 | M8727 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP | 6.79e-04 | 199 | 250 | 8 | M5239 | |
| Coexpression | DOANE_BREAST_CANCER_ESR1_UP | 6.97e-04 | 111 | 250 | 6 | M19439 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 7.01e-04 | 200 | 250 | 8 | M9439 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 7.01e-04 | 200 | 250 | 8 | M3399 | |
| Coexpression | GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN | 7.01e-04 | 200 | 250 | 8 | M4656 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP | 7.01e-04 | 200 | 250 | 8 | M5994 | |
| Coexpression | GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP | 7.01e-04 | 200 | 250 | 8 | M5819 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN | 7.01e-04 | 200 | 250 | 8 | M8656 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | IQGAP2 ERCC6L USP9X CLASP2 NCAPG TULP4 PCDH11X ALCAM UTRN SENP5 HEATR1 ECPAS TFRC PHF3 SUPT16H KLHDC10 HDAC2 | 3.04e-06 | 397 | 240 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | IQGAP2 USP9X IRF6 CLASP2 RYR3 PTPN4 FGD4 SULF1 VPS13A PCDH11X FAM135A TBX5 NIBAN1 TBX4 CLASP1 SLC5A9 GRIA2 REV3L ECPAS TFRC ANKRD44 SLC15A2 PHF3 SUPT16H EIF3A | 5.24e-06 | 806 | 240 | 25 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | IQGAP2 ERCC6L USP9X CLASP2 GCNT1 THSD1 NCAPG TULP4 SULF1 PCDH11X ALCAM UTRN TBX5 SENP5 NIBAN1 TBX4 HEATR1 ECPAS TFRC SLC15A2 PHF3 SUPT16H KLHDC10 DEPDC1B HDAC2 | 5.84e-06 | 811 | 240 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.64e-05 | 129 | 240 | 9 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DDX19B ERCC6L AVL9 USP9X LYST ACSL1 NCAPG TRANK1 SGPL1 VPS13A HERC1 DNA2 FAM135A USP28 HEATR1 TFRC PAPOLG MTOR DGKK CENPI SUPT16H UBA6 PRKDC POLD3 | 2.12e-05 | 820 | 240 | 24 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | IQGAP2 USP9X CLASP2 PTPN4 FGD4 VPS13A PCDH11X FAM135A CLASP1 GRIA2 REV3L ECPAS TFRC PHF3 SUPT16H | 2.16e-05 | 369 | 240 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | SIDT1 TOGARAM1 ELOVL7 VPS13A HERC1 UTRN USP28 REV3L PAPOLG ANKRD44 SLC15A2 PRKDC LY9 SLC12A7 | 3.11e-05 | 336 | 240 | 14 | GSM538413_500 |
| CoexpressionAtlas | NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3 | IL10RA SIDT1 GCNT1 DOCK5 PTPN4 NCAPG MKI67 GPR171 ABCG2 PLD1 SMCHD1 HELZ2 TOP2A MX2 | 8.04e-05 | 367 | 240 | 14 | GSM538309_500 |
| CoexpressionAtlas | Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4 | CLEC5A F5 LYST ELOVL7 TINAGL1 DOCK5 ACSL1 FGD4 PIP5K1B PLD1 DNAH6 NIBAN1 IL1B DEPDC1B HCK | 8.21e-05 | 415 | 240 | 15 | GSM605846_500 |
| CoexpressionAtlas | Myeloid Cells, GN.Arth.BM, CD11b+ Ly6-G+, Bone marrow, avg-3 | CLEC5A F5 LYST ELOVL7 TINAGL1 DOCK5 ACSL1 FGD4 PIP5K1B PLD1 DNAH6 NIBAN1 IL1B DEPDC1B HCK | 9.37e-05 | 420 | 240 | 15 | GSM854303_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | SELENOT IQGAP2 USP9X CLASP2 SULF1 PCDH11X CLASP1 GRIA2 REV3L ECPAS PHF3 KLHDC10 HDAC2 | 1.05e-04 | 330 | 240 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_1000 | SELENOT DHX36 PIPOX GCNT1 ELOVL7 ACSL1 NCAPG CPQ PI4KB AK4 HERC1 SLC23A1 VDR ECPAS PAPSS2 TFRC ACE2 SLC15A2 SH3D19 LRP2 EIF3A | 1.60e-04 | 761 | 240 | 21 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DDX19B ERCC6L USP9X PIPOX C2CD5 ACSL1 NCAPG VPS13A POLR1B PUM3 GPR171 DNA2 FAM135A TBX4 USP28 HEATR1 TFRC MTOR GET3 CENPI SUPT16H PRKDC | 1.72e-04 | 822 | 240 | 22 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO5 RYR3 FREM2 TRANK1 PCDH11X PCDH15 DNAH5 DNAH9 DNAH10 MROH2A ODAD2 LOXHD1 DGKK LRP2 | 2.83e-12 | 184 | 250 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO5 RYR3 FREM2 TRANK1 PCDH11X PCDH15 DNAH5 DNAH9 DNAH10 MROH2A ODAD2 LOXHD1 DGKK LRP2 | 2.83e-12 | 184 | 250 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO5 RYR3 FREM2 TRANK1 PCDH11X PCDH15 DNAH5 DNAH9 DNAH10 MROH2A ODAD2 LOXHD1 DGKK LRP2 | 2.83e-12 | 184 | 250 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | HSP90B1 IQGAP2 USP9X IQGAP1 ACSL1 FGD4 HERC1 GNS SMCHD1 PAPSS2 MRPL15 SUPT16H | 1.62e-09 | 200 | 250 | 12 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | CPAMD8 SIDT1 IRF6 NOMO2 FGD4 SULF1 PIP5K1B PCDH11Y PAPSS2 NOMO1 NOMO3 | 1.26e-08 | 192 | 250 | 11 | e911e286da26202853f9650ba3cdefe5a5c9b585 |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CSMD2 F5 RYR3 ACSL1 SULF1 AGBL1 DNAH9 NIBAN1 AOX1 STEAP4 IL1B | 1.48e-08 | 195 | 250 | 11 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CSMD2 F5 RYR3 ACSL1 SULF1 AGBL1 DNAH9 NIBAN1 AOX1 STEAP4 IL1B | 1.48e-08 | 195 | 250 | 11 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | EFCAB11 IQGAP2 NMRAL1 NCAPG MKI67 GRIA2 LMNB2 TENM3 TOP2A DMTN | 7.43e-08 | 179 | 250 | 10 | df4d0b2fe47d2c7def729b3217cb01ced01495ff |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | RMI1 VPS13A MKI67 ALCAM VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | RMI1 VPS13A MKI67 ALCAM VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | RMI1 VPS13A MKI67 ALCAM VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | d31d4116d1d196633784863781fa45673607a421 |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | MATR3 RMI1 VPS13A MKI67 VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | HSP90B1 CLEC5A MATR3 ACSL1 ADPRH NCAPG MKI67 HEATR1 TOP2A MX2 | 9.62e-08 | 184 | 250 | 10 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | RMI1 VPS13A MKI67 ALCAM VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | a8c6028d745aaa6ee7842259238694cb50ce0526 |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | RMI1 VPS13A MKI67 ALCAM VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | MATR3 RMI1 VPS13A MKI67 VAT1 DNAH10 HEATR1 ECPAS CENPI TOP2A | 9.62e-08 | 184 | 250 | 10 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERBB4 DCDC1 EFCAB12 DNAH5 DNAH6 DNAH9 SPEF1 DNAH10 ODAD2 TCTN2 | 1.01e-07 | 185 | 250 | 10 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | AVL9 NOMO2 ALCAM DNA2 CLASP1 SMCHD1 HEATR1 TFRC ANKRD44 PRKDC | 1.06e-07 | 186 | 250 | 10 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | LYST IQGAP1 NOMO2 ALCAM DNA2 SMCHD1 HEATR1 TFRC ANKRD44 PRKDC | 1.36e-07 | 191 | 250 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DCDC1 EFCAB12 HSD17B13 DNAH5 DNAH6 DNAH9 DNAH10 ODAD2 SEC14L3 GSTM2 | 1.50e-07 | 193 | 250 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP9X IQGAP1 TULP4 VPS13A HERC1 GNS VDR CACNA1D REV3L PAPSS2 | 1.65e-07 | 195 | 250 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | SELENOT IQGAP2 CLEC5A MATR3 F5 IQGAP1 ACSL1 NIBAN1 ECPAS YWHAB | 1.73e-07 | 196 | 250 | 10 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.84e-07 | 150 | 250 | 9 | e020dbcf85c0ba7ad667b8bbeb6bbcfc135c9bb7 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.84e-07 | 150 | 250 | 9 | 01c526e1e3007e71e416c317549fddd2919b14e9 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.84e-07 | 150 | 250 | 9 | b7f5bf9af7ed50aad4da1c71d37b8b9709e6ce85 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.84e-07 | 150 | 250 | 9 | d44c02402e59a45e40b8fffbe71284032b5e7c92 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.84e-07 | 150 | 250 | 9 | edbc1d29d213bf5908592135700e0d80e123c923 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | RMI1 VPS13A MKI67 ALCAM VAT1 DNAH10 HEATR1 CSE1L CENPI TOP2A | 2.09e-07 | 200 | 250 | 10 | 118321ac443feb42aee171baccfc4610f00a8822 |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | ACSL1 RMI1 MSANTD3 NCAPG MKI67 DNA2 LMCD1 STEAP4 DEPDC1B TOP2A | 2.09e-07 | 200 | 250 | 10 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-07 | 157 | 250 | 9 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.80e-07 | 168 | 250 | 9 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-07 | 169 | 250 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-07 | 183 | 250 | 9 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-07 | 183 | 250 | 9 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 186 | 250 | 9 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 187 | 250 | 9 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-06 | 187 | 250 | 9 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-06 | 187 | 250 | 9 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.28e-06 | 189 | 250 | 9 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-06 | 190 | 250 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.40e-06 | 191 | 250 | 9 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 192 | 250 | 9 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.59e-06 | 194 | 250 | 9 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | BLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.59e-06 | 194 | 250 | 9 | 6a0cbb9d5c5c4effb02dff654c6c3b184026875c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 195 | 250 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-06 | 196 | 250 | 9 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.73e-06 | 196 | 250 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-06 | 196 | 250 | 9 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-06 | 196 | 250 | 9 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-06 | 196 | 250 | 9 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.81e-06 | 197 | 250 | 9 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.81e-06 | 197 | 250 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-06 | 197 | 250 | 9 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.88e-06 | 198 | 250 | 9 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ERBB4 ACADSB SLC39A6 ALCAM DNAH5 NIBAN1 STEAP4 MYRFL SLC15A2 | 1.88e-06 | 198 | 250 | 9 | 6ba5e5970109a04ed968bac7ff099ae250c579dc |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-06 | 199 | 250 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 2.05e-06 | 200 | 250 | 9 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.05e-06 | 200 | 250 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.05e-06 | 200 | 250 | 9 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-06 | 200 | 250 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.05e-06 | 200 | 250 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 2.05e-06 | 200 | 250 | 9 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.05e-06 | 200 | 250 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-06 | 200 | 250 | 9 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 164 | 250 | 8 | 7dbe34a98a3b475c1ba678db8a5494c0c6a91e2d | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 164 | 250 | 8 | febcb8f8b305aa94e21131fa83d2890f7a6838fc | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 165 | 250 | 8 | 0ae39c9a6d1265d65dc0660924612cfe11e489ec | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 165 | 250 | 8 | a5ed8c331d5551cd8bce50bdc31cb893218317cd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 165 | 250 | 8 | 686cf89077cc7b744a6127de2b34d8c27da8b6c4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.81e-06 | 167 | 250 | 8 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.81e-06 | 167 | 250 | 8 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-06 | 170 | 250 | 8 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.72e-06 | 171 | 250 | 8 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 171 | 250 | 8 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 174 | 250 | 8 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.07e-06 | 176 | 250 | 8 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.07e-06 | 176 | 250 | 8 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.37e-06 | 177 | 250 | 8 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.37e-06 | 177 | 250 | 8 | f4ddf0ef0eade13b9835a5684a8dbb6f71be4697 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.68e-06 | 178 | 250 | 8 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 7.68e-06 | 178 | 250 | 8 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-06 | 179 | 250 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-06 | 179 | 250 | 8 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-06 | 181 | 250 | 8 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.68e-06 | 181 | 250 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-06 | 181 | 250 | 8 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.04e-06 | 182 | 250 | 8 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.04e-06 | 182 | 250 | 8 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-06 | 183 | 250 | 8 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-06 | 183 | 250 | 8 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 9.79e-06 | 184 | 250 | 8 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 9.79e-06 | 184 | 250 | 8 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.82e-06 | 132 | 250 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.02e-05 | 185 | 250 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-05 | 185 | 250 | 8 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-05 | 186 | 250 | 8 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 186 | 250 | 8 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 186 | 250 | 8 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 187 | 250 | 8 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-05 | 187 | 250 | 8 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 1.72e-06 | 34 | 250 | 6 | ctd:C569670 | |
| Drug | Raloxifene Hydrochloride | IL10RA HSP90B1 ERBB4 CYP3A4 MATR3 GCNT1 PTGFRN IQGAP1 ACSL1 PTPN4 PIAS3 MKI67 SLC39A6 ALCAM WDR1 VDR LMCD1 PCDHGA3 AOX1 LMNB2 PHC2 TFRC CRYBB2 PRKDC IL1B TOP2A | 3.06e-06 | 857 | 250 | 26 | ctd:D020849 |
| Drug | E 5110 | 4.41e-06 | 11 | 250 | 4 | CID006438164 | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; HL60; HT_HG-U133A | HSP90B1 ACSL1 PI4KB SLC39A6 DLG1 WDR1 UTRN GNS CBFB UBA6 SLC33A1 | 7.09e-06 | 186 | 250 | 11 | 1323_DN |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | HSP90B1 AVL9 LYST MAGEF1 PLCB3 GNS RANGAP1 REV3L IGBP1 KLHDC10 TCTN2 | 1.16e-05 | 196 | 250 | 11 | 7087_DN |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HG-U133A | HSP90B1 CYP3A4 LYST IQGAP1 NCAPG ECPAS PHF3 ELF4 EIF3A KLHDC10 TCTN2 | 1.28e-05 | 198 | 250 | 11 | 782_UP |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | AVL9 MATR3 TOGARAM1 CLASP2 MAGEF1 FOCAD VPS13A PAN2 PLCB3 CSE1L NNT | 1.34e-05 | 199 | 250 | 11 | 1797_UP |
| Drug | Lithocholic Acid | CYP3A4 ACSL1 ABCG2 PLD1 WDR1 VDR RANGAP1 TFRC GSTM2 FADS1 LRP2 IL1B | 1.50e-05 | 240 | 250 | 12 | ctd:D008095 |
| Drug | Cholic Acid | 1.86e-05 | 75 | 250 | 7 | ctd:D019826 | |
| Drug | nimesulide | CYP3A4 PSMB5 TATDN2 PSMD1 IRF6 ACSL1 HSD17B13 MKI67 AK4 ABCG2 ALCAM GNS IPO5 DMGDH GNE COQ6 GLYATL2 STEAP4 XPC PAPSS2 NOMO1 TFRC PPP2R5A FADS1 GHITM CACYBP IL1B NNT SLC33A1 HDAC2 | 2.41e-05 | 1202 | 250 | 30 | ctd:C012655 |
| Drug | Alfentanil | 2.55e-05 | 6 | 250 | 3 | ctd:D015760 | |
| Drug | climbazole | 2.55e-05 | 6 | 250 | 3 | CID000037907 | |
| Drug | Theophylline | CYP3A4 PSMB5 PIPOX C2CD5 BRAF SUPT6H DLG1 POLR1B CAMK2D COX5B NOMO1 EPG5 GSTM2 ANKRD44 EIF3A IL1B NNT HDAC2 | 2.65e-05 | 532 | 250 | 18 | ctd:D013806 |
| Drug | bunitrolol | 3.02e-05 | 17 | 250 | 4 | CID000002473 | |
| Drug | musk xylene | 3.02e-05 | 17 | 250 | 4 | CID000062329 | |
| Disease | Colorectal Carcinoma | CPAMD8 ATP6V1E1 MCF2L2 GPR87 F5 STK11 NCAPG BRAF VPS13A PCDH11X MKI67 PAN2 ABCG2 NODAL NLRP8 LMNB2 TFRC FADS1 CSE1L ERGIC3 LRP2 POLD3 SLC33A1 | 1.83e-08 | 702 | 240 | 23 | C0009402 |
| Disease | Breast Carcinoma | ERBB4 CYP3A4 LRRC37A2 LRRC37A BRAF MKI67 SLC39A6 ABCG2 DNMT1 VDR VPS39 MRPL13 TFRC IGBP1 MTOR KLHDC10 IL1B TOP2A | 5.08e-07 | 538 | 240 | 18 | C0678222 |
| Disease | tacrolimus measurement | 2.11e-06 | 4 | 240 | 3 | EFO_0008458 | |
| Disease | cancer (implicated_via_orthology) | BRAF DLG1 PIP5K1B DNA2 IPO5 PHC2 PPP2R5A PPP2R5E MTOR GET3 HCK TOP2A | 2.28e-06 | 268 | 240 | 12 | DOID:162 (implicated_via_orthology) |
| Disease | Situs ambiguus | 5.43e-06 | 15 | 240 | 4 | C0266642 | |
| Disease | Mammary Carcinoma, Human | CYP3A4 LRRC37A2 LRRC37A MKI67 SLC39A6 ABCG2 DNMT1 VDR VPS39 MRPL13 TFRC IGBP1 MTOR KLHDC10 IL1B TOP2A | 7.23e-06 | 525 | 240 | 16 | C4704874 |
| Disease | Mammary Neoplasms, Human | CYP3A4 LRRC37A2 LRRC37A MKI67 SLC39A6 ABCG2 DNMT1 VDR VPS39 MRPL13 TFRC IGBP1 MTOR KLHDC10 IL1B TOP2A | 7.23e-06 | 525 | 240 | 16 | C1257931 |
| Disease | Mammary Neoplasms | CYP3A4 LRRC37A2 LRRC37A MKI67 SLC39A6 ABCG2 DNMT1 VDR VPS39 MRPL13 TFRC IGBP1 MTOR KLHDC10 IL1B TOP2A | 7.58e-06 | 527 | 240 | 16 | C1458155 |
| Disease | Malignant neoplasm of breast | ERBB4 CYP3A4 LRRC37A2 MCF2L2 ITGA9 LRRC37A BRAF MKI67 SLC39A6 ABCG2 DNAH9 DNMT1 NLRP8 VDR VPS39 MRPL13 CBFB EPG5 TFRC IGBP1 MTOR KLHDC10 IL1B TOP2A | 8.38e-06 | 1074 | 240 | 24 | C0006142 |
| Disease | serum metabolite measurement | CYP3A7 CYP3A4 CYP3A5 TAAR3P TINAGL1 SERPINB13 PCDH15 TXNDC16 ABCG2 ALCAM WDR1 AGBL1 DNMT1 DMGDH REV3L KBTBD2 PAPSS2 FADS1 TENM3 KMT5B DNAH17 GHITM | 1.08e-05 | 945 | 240 | 22 | EFO_0005653 |
| Disease | melanoma | 3.92e-05 | 248 | 240 | 10 | C0025202 | |
| Disease | Vitamin D Deficiency | 6.59e-05 | 2 | 240 | 2 | C0042870 | |
| Disease | MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1 | 6.59e-05 | 2 | 240 | 2 | 155600 | |
| Disease | Melanoma, cutaneous malignant, susceptibility to, 1 | 6.59e-05 | 2 | 240 | 2 | cv:C1835047 | |
| Disease | Schizophrenia | IL10RA ERBB4 EFCAB11 CYP3A4 CYP3A5 CSMD2 PIK3C3 GLO1 DLG1 DNMT1 IPO5 VPS39 GRIA2 GSTM2 MTOR LRP2 IL1B RAI1 HDAC2 | 1.23e-04 | 883 | 240 | 19 | C0036341 |
| Disease | X-12063 measurement | 1.50e-04 | 186 | 240 | 8 | EFO_0021283 | |
| Disease | Malignant neoplasm of prostate | HSP90B1 CYP3A4 CYP3A5 GCNT1 BRAF DNMT1 VDR USP28 PCDH11Y AOX1 STEAP4 LRP2 EIF3A PRKDC TOP2A | 1.75e-04 | 616 | 240 | 15 | C0376358 |
| Disease | Prostatic Neoplasms | HSP90B1 CYP3A4 CYP3A5 GCNT1 BRAF DNMT1 VDR USP28 PCDH11Y AOX1 STEAP4 LRP2 EIF3A PRKDC TOP2A | 1.75e-04 | 616 | 240 | 15 | C0033578 |
| Disease | Familial atypical multiple mole melanoma syndrome | 1.97e-04 | 3 | 240 | 2 | cv:C2314896 | |
| Disease | Steroid resistant nephrotic syndrome of childhood | 1.97e-04 | 3 | 240 | 2 | C3266102 | |
| Disease | Steroid-resistant nephrotic syndrome | 1.97e-04 | 3 | 240 | 2 | C0403397 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 2.75e-04 | 16 | 240 | 3 | OBA_2045093 | |
| Disease | pancreatic cancer (is_implicated_in) | 3.17e-04 | 112 | 240 | 6 | DOID:1793 (is_implicated_in) | |
| Disease | Cutaneous Melanoma | 3.41e-04 | 41 | 240 | 4 | C0151779 | |
| Disease | secondary hyperparathyroidism (biomarker_via_orthology) | 3.91e-04 | 4 | 240 | 2 | DOID:12466 (biomarker_via_orthology) | |
| Disease | estrone conjugate measurement | 3.91e-04 | 4 | 240 | 2 | EFO_0007971 | |
| Disease | metabolonic lactone sulfate measurement | 4.68e-04 | 19 | 240 | 3 | EFO_0800659 | |
| Disease | Squamous cell carcinoma | 5.46e-04 | 124 | 240 | 6 | C0007137 | |
| Disease | interstitial cystitis (is_marker_for) | 6.48e-04 | 5 | 240 | 2 | DOID:13949 (is_marker_for) | |
| Disease | tauro-beta-muricholate measurement | 6.48e-04 | 5 | 240 | 2 | EFO_0800213 | |
| Disease | Distal Muscular Dystrophies | 6.48e-04 | 5 | 240 | 2 | C0751336 | |
| Disease | glyco-beta-muricholate measurement | 6.48e-04 | 5 | 240 | 2 | EFO_0800569 | |
| Disease | anxiety disorder (implicated_via_orthology) | 7.30e-04 | 22 | 240 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | PR interval | ITGA9 STK11 FREM2 DLG1 TBX5 CACNA1D USP28 CAMK2D LMNB2 TRAPPC3 SLC12A7 CNOT1 | 8.03e-04 | 495 | 240 | 12 | EFO_0004462 |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 9.67e-04 | 6 | 240 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0800294 | |
| Disease | Fuchs' endothelial dystrophy (is_implicated_in) | 9.67e-04 | 6 | 240 | 2 | DOID:11555 (is_implicated_in) | |
| Disease | gout | 1.16e-03 | 196 | 240 | 7 | EFO_0004274 | |
| Disease | obesity (biomarker_via_orthology) | 1.32e-03 | 147 | 240 | 6 | DOID:9970 (biomarker_via_orthology) | |
| Disease | X-24574 measurement | 1.35e-03 | 7 | 240 | 2 | EFO_0800897 | |
| Disease | Lymphopenia | 1.35e-03 | 7 | 240 | 2 | C0024312 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.55e-03 | 206 | 240 | 7 | C0152013 | |
| Disease | Familial melanoma | 1.79e-03 | 8 | 240 | 2 | cv:C1512419 | |
| Disease | Malignant melanoma of skin | 1.79e-03 | 8 | 240 | 2 | cv:C0151779 | |
| Disease | Melanoma | 1.79e-03 | 8 | 240 | 2 | cv:C0025202 | |
| Disease | familial atrial fibrillation | 1.79e-03 | 156 | 240 | 6 | C3468561 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.79e-03 | 156 | 240 | 6 | C0007131 | |
| Disease | Persistent atrial fibrillation | 1.79e-03 | 156 | 240 | 6 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 1.79e-03 | 156 | 240 | 6 | C0235480 | |
| Disease | Bipolar Disorder | HSP90B1 ERBB4 ITGA9 TRANK1 PIK3C3 GLO1 DNMT1 VDR CACNA1D GRIA2 IL1B | 1.95e-03 | 477 | 240 | 11 | C0005586 |
| Disease | Malignant tumor of colon | 1.97e-03 | 159 | 240 | 6 | C0007102 | |
| Disease | Early Pregnancy Loss | 2.01e-03 | 109 | 240 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 2.01e-03 | 109 | 240 | 5 | C0000786 | |
| Disease | Miscarriage | 2.01e-03 | 109 | 240 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 2.01e-03 | 109 | 240 | 5 | C0000822 | |
| Disease | Atrial Fibrillation | 2.04e-03 | 160 | 240 | 6 | C0004238 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.07e-03 | 66 | 240 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | familial melanoma (is_implicated_in) | 2.28e-03 | 9 | 240 | 2 | DOID:6846 (is_implicated_in) | |
| Disease | Situs ambiguous | 2.28e-03 | 9 | 240 | 2 | C1167664 | |
| Disease | Gout | 2.28e-03 | 9 | 240 | 2 | C0018099 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 2.28e-03 | 9 | 240 | 2 | EFO_0800278 | |
| Disease | Cleft palate with cleft lip | 2.28e-03 | 9 | 240 | 2 | C0158646 | |
| Disease | hyperuricemia | 2.42e-03 | 33 | 240 | 3 | EFO_0009104 | |
| Disease | Adenocarcinoma | 2.63e-03 | 116 | 240 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 2.63e-03 | 116 | 240 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.63e-03 | 116 | 240 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.63e-03 | 116 | 240 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.63e-03 | 116 | 240 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.63e-03 | 116 | 240 | 5 | C0205641 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 2.64e-03 | 34 | 240 | 3 | DOID:9952 (is_marker_for) | |
| Disease | visual epilepsy (implicated_via_orthology) | 2.64e-03 | 34 | 240 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | cervical cancer | 2.64e-03 | 34 | 240 | 3 | C4048328 | |
| Disease | Polydactyly | 2.73e-03 | 117 | 240 | 5 | C0152427 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.84e-03 | 10 | 240 | 2 | EFO_0022090 | |
| Disease | alopecia areata (is_marker_for) | 2.84e-03 | 10 | 240 | 2 | DOID:986 (is_marker_for) | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 2.84e-03 | 10 | 240 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 2.84e-03 | 10 | 240 | 2 | EFO_0008465 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.84e-03 | 10 | 240 | 2 | EFO_0800289 | |
| Disease | right ventricular systolic volume measurement | 2.87e-03 | 35 | 240 | 3 | EFO_0021815 | |
| Disease | Myocardial Ischemia | 3.27e-03 | 176 | 240 | 6 | C0151744 | |
| Disease | Cerebral Infarction, Left Hemisphere | 3.45e-03 | 11 | 240 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 3.45e-03 | 11 | 240 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 3.45e-03 | 11 | 240 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 3.45e-03 | 11 | 240 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 3.45e-03 | 11 | 240 | 2 | C0007785 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 3.45e-03 | 11 | 240 | 2 | EFO_0801531 | |
| Disease | Posterior Choroidal Artery Infarction | 3.45e-03 | 11 | 240 | 2 | C0887799 | |
| Disease | phosphatidylcholine 32:0 measurement | 3.45e-03 | 11 | 240 | 2 | EFO_0010372 | |
| Disease | response to virus | 3.45e-03 | 11 | 240 | 2 | GO_0009615 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 3.45e-03 | 11 | 240 | 2 | EFO_0800295 | |
| Disease | Situs Inversus | 3.45e-03 | 11 | 240 | 2 | C0037221 | |
| Disease | obsolete_red blood cell distribution width | AVL9 LRRC37A2 PSMB5 IQGAP1 DOCK5 NEO1 SGPL1 VPS13A AK4 PLD1 HERC1 SLC23A1 CLASP1 KBTBD2 CBFB EPG5 TFRC FADS1 LOXHD1 HELZ2 SLC12A7 | 3.46e-03 | 1347 | 240 | 21 | EFO_0005192 |
| Disease | Disproportionate short stature | 3.63e-03 | 77 | 240 | 4 | C0878659 | |
| Disease | Malignant neoplasm of brain | 3.63e-03 | 38 | 240 | 3 | C0153633 | |
| Disease | hemoglobin A1 measurement | PSMB5 ACSL1 TULP4 VPS13A PLCB3 ABCG2 PLD1 SH2B3 FADS1 ELF4 SLC12A7 | 3.76e-03 | 520 | 240 | 11 | EFO_0007629 |
| Disease | HbA1c measurement | CPAMD8 CYP3A7 PIPOX VPS13A PLCB3 ABCG2 PLD1 VDR CLASP1 ASB15 TFRC FADS1 RAI1 | 3.76e-03 | 675 | 240 | 13 | EFO_0004541 |
| Disease | Graves' disease (is_implicated_in) | 3.91e-03 | 39 | 240 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | lactate measurement | 3.91e-03 | 39 | 240 | 3 | EFO_0007745 | |
| Disease | Brain Neoplasms | 3.91e-03 | 39 | 240 | 3 | C0006118 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSIQKVIGFAKMIPG | 236 | P11473 | |
| DTYKLLFAIIKMPAV | 296 | O00400 | |
| PAIVALVYNVLKAFM | 401 | Q16537 | |
| LGKAEYLKNNILSMP | 1216 | Q15303 | |
| IEKPTYFMKLDAGVN | 231 | Q5NDL2 | |
| LAQKPYAGILSESMK | 931 | Q9HCE0 | |
| VNILLFMGYSTKPQL | 511 | P15056 | |
| ATQPESKVFYLKMKG | 111 | P31946 | |
| LYENPNFTGKKMEII | 111 | P43320 | |
| KIVIQLKMGAKTYPD | 251 | Q9Y646 | |
| VTYAEVLGIKMPIKE | 141 | Q75V66 | |
| YQITGPVEIFMNKFK | 3336 | Q7Z408 | |
| APIFGLMQEKIYISK | 496 | P26358 | |
| KLIPGLKIIVVMDAY | 216 | P33121 | |
| KLKEMFPIIAQYGDV | 141 | P20815 | |
| AQLYPISIFIKPKSM | 821 | Q12959 | |
| CIVYFMLGLKPKADA | 491 | Q9UNQ0 | |
| TPLLIAVKKGSYDMV | 146 | Q8WXK1 | |
| GAMLQYAVSLLKPTK | 311 | Q9Y2Z9 | |
| LFLVMANVDPTIGYK | 216 | P45954 | |
| QPMYLGFEKDVFKTI | 261 | Q8WUY9 | |
| FMPGTIQLTAKDILY | 141 | P0C7M7 | |
| LTNKKMIFVPSYINI | 251 | Q7Z5P4 | |
| ESVTYMRLKGQDIPK | 691 | Q6DHV5 | |
| KALLYPGDKIIFQMD | 416 | Q6NXP0 | |
| NGAMELLFKVITPYT | 141 | Q96MI9 | |
| FYLEVSQILKKMDPV | 526 | Q06278 | |
| KTELEKYGIQMPAFS | 186 | P46940 | |
| SSVDKIPYGMRFIAK | 1151 | P46940 | |
| IPYGMRFIAKVLKDS | 1156 | P46940 | |
| EDKVKAIANLYGPLM | 526 | P46060 | |
| YLVAGKLFGLQEAMK | 1836 | Q7Z5J4 | |
| TFDNVLPGKYKISIM | 546 | P69849 | |
| LTQFDQLYRKKPGMT | 656 | P29074 | |
| KFLMYGSKPQIAEII | 221 | Q15397 | |
| MLVDLLAKNKSIPFY | 81 | Q8NH69 | |
| VITPKMLGNFLYKQN | 76 | P0C7N1 | |
| LRTMKKVGFIGYAPN | 431 | Q504Q3 | |
| TPLKGFMREKEYLQV | 266 | O95340 | |
| IMVAYKTFLDPNAVL | 606 | M0R2J8 | |
| KAKYPTEMIIATRFL | 661 | Q5KSL6 | |
| QKSLVMSGPYELKAL | 131 | P01584 | |
| TFDNVLPGKYKISIM | 546 | Q5JPE7 | |
| KLPALKYLDMGTTLV | 986 | O60309 | |
| NIVKMAILPKVIYRF | 811 | O00370 | |
| LAEPYGKIKNYILMR | 516 | P43243 | |
| LYGDPRKVMTKDLVQ | 236 | Q96M61 | |
| EMVKYVIGDLKILFP | 101 | Q9HAY2 | |
| KLPALKYLDMGTTLV | 986 | A6NM11 | |
| KLPALKYLDMGTTLV | 986 | A6NMS7 | |
| VVLSLLKMPEKYVGQ | 196 | Q9HBL8 | |
| QKVIKRAEVSPMYGV | 296 | Q9H3K2 | |
| ELAQKIKMYFALAPI | 201 | Q5VYY2 | |
| LVTLPGFNTMEKIKY | 351 | Q86W28 | |
| LVYQFKEMPKDLVVI | 286 | Q99607 | |
| LKVRTPGIYMLIFDN | 1436 | Q9BQS8 | |
| GEMAKQYIEKSLLVP | 51 | P27144 | |
| KFTPKYILRAGQMVT | 516 | Q03252 | |
| EMGNLVLKEPKVVLY | 471 | Q4FZB7 | |
| DLPKMQFKERIYTGS | 2126 | Q5SZK8 | |
| RVYKPKVIEALQGMF | 601 | Q15751 | |
| MQIYGEKGKTEVLFL | 836 | Q8IVV2 | |
| YQLELALPAMKGKNT | 246 | O95786 | |
| KLKEMVPIIAQYGDV | 141 | P08684 | |
| PAIINKMYKVYLGDI | 296 | Q5VYK3 | |
| KMKERAIQTLGYFPV | 856 | Q5VYK3 | |
| KYQMLLKGLLDFESP | 761 | Q86YR7 | |
| QLLMKPDYNVKFSLG | 806 | Q9P2D6 | |
| EELKLLKLPGFMYSE | 1211 | Q9P2D6 | |
| YTINIMELKTNGPRK | 371 | P42262 | |
| LKYLLVPAFQGALTM | 76 | P78318 | |
| GKKPSRIYGQAMAII | 201 | Q6PID8 | |
| SKVVAFMKSPVGQYL | 31 | Q96B96 | |
| DPKKSLDFYTRVLGM | 41 | Q04760 | |
| IVPKMASDFLYGNKS | 76 | Q8NG80 | |
| EAGKVYLKAPMILNG | 91 | Q13951 | |
| VPDAKRTGMQKVLYS | 291 | O14986 | |
| IMLAAKKGLDPYNVL | 51 | P10606 | |
| DPSEGLMNVLKKIYE | 186 | Q9HB71 | |
| MEALGKLKQFDAYPK | 1 | Q9Y282 | |
| GDILQKLAPFLKMYG | 286 | Q96M96 | |
| KIYRIQEPGFAKMIS | 121 | O14626 | |
| LPEMLKLYSQFLGKQ | 131 | P28161 | |
| TFDNVLPGKYKISIM | 546 | Q15155 | |
| DKSVVVQGLYKSMPK | 241 | Q8IY47 | |
| GLKPIEMFYLKVFGT | 286 | Q96LU7 | |
| ALAKGYLKQDPLEMT | 491 | Q13651 | |
| LGKEKIASMLPEQLY | 106 | Q96H12 | |
| LKLKYVMQPDGIAVD | 4136 | P98164 | |
| KDAKGQTPLMLAVAY | 666 | Q8N8A2 | |
| IYAFMGTPVQKLDLT | 1551 | P46013 | |
| MQFKLVYKTGDVPLI | 61 | Q9BZA7 | |
| PLIKMACAGTFVKEY | 181 | Q8NGP4 | |
| MCKILGKEFQQYLPV | 611 | O00410 | |
| EQVVKLMVPLLKFYF | 701 | O00410 | |
| VITPKMLGNFLYKQN | 76 | P0C7N5 | |
| LKVVKPFGDSRMYSI | 141 | Q9BY21 | |
| TQKLGLQYMELIPKE | 126 | Q9NZU5 | |
| KKIFMGLIPYDQSGF | 211 | Q86YD1 | |
| QVSYILDKMPGKIAE | 276 | Q9Y5H0 | |
| KGKPYLTLEQLMDFI | 236 | Q01970 | |
| MPKYLNFVKGVVDSD | 426 | P14625 | |
| TLLKKMPDVEQLYGL | 96 | Q6PIJ6 | |
| KKEKGQMPRVYFVLL | 521 | Q13797 | |
| IYTQKLIDAMKPFGV | 36 | Q9BWT3 | |
| FSKRIYKGMVAPDAV | 926 | Q96QU1 | |
| VKTYVLNPKSITMGE | 1786 | Q9C0G6 | |
| KEPIYIITEFMAKGS | 326 | P08631 | |
| LMNVYCNKILKPVDG | 286 | Q96PB1 | |
| NKKMEDAKFYLTLPG | 576 | Q9H7D0 | |
| DYSKLAPIMFGIKTE | 21 | Q9Y223 | |
| SEKANLMILFDKYLP | 2286 | Q9UFH2 | |
| VGKKQPALDVLYDVM | 21 | Q14152 | |
| YFVTSLGPKLMENRK | 46 | A1L3X0 | |
| KLPSYGMQKELVNLI | 206 | Q9H2U1 | |
| FYISPVNKLVGALMT | 206 | Q8NBF6 | |
| EVYMKLSVPKGIQFV | 836 | Q8IZJ3 | |
| LQTGKVIEQMGKFYP | 176 | Q9UMR2 | |
| VIEQMGKFYPELKLA | 181 | Q9UMR2 | |
| FKIPFVREYLMAKGV | 141 | Q58HT5 | |
| GLKKYEEPLQSMISQ | 461 | Q86UU0 | |
| KQALTIVGTLPFTYM | 441 | Q9BYF1 | |
| VKKYMNSLLIGELSP | 81 | O60427 | |
| YEPVIRLKGQMKTQL | 1756 | Q99698 | |
| LNGLEKNIPMSEYKL | 2481 | Q99698 | |
| IAKTIDPELLGKMNY | 491 | P15586 | |
| GLLFGPYESQEKMKV | 306 | Q9UI17 | |
| RPKENVTIMVKSYLG | 91 | Q9HBG7 | |
| PTKVKGYDNLFAMEI | 91 | O43681 | |
| KEFPMVSAGTEKYIL | 306 | A6NC97 | |
| PSYIAKDLMKVLQGV | 1011 | Q9H583 | |
| GMAKLLDKLQSSYFP | 276 | Q9NYC9 | |
| YNKVMKTLLEVEFPL | 746 | Q9NYC9 | |
| KIMDANYFGPITLTK | 146 | A6NNS2 | |
| NYSRKQLVKVMPGLI | 556 | Q8NDH2 | |
| KLKEMVPIIAQYGDV | 141 | P24462 | |
| PGMKQQVLVFYTKLL | 101 | Q5W0V3 | |
| LQMAVGYFEKGPIKA | 66 | Q92674 | |
| MAYGVPRKNTVKTIL | 1 | Q96KX1 | |
| KYLINLCGMDFPIKT | 211 | Q02742 | |
| QTALMAKYKGPALAL | 311 | Q9BYK8 | |
| ESYGQIFKPIISKVM | 236 | Q92769 | |
| KVLLSKDYTLIVGMP | 636 | P51530 | |
| KIYPYEMLVVTNKGR | 341 | Q08495 | |
| YPELLKVQKEMSGLR | 1251 | Q8IVF4 | |
| LKQLEMSIKYGTPFL | 3466 | Q8IVF4 | |
| AVVMLFGYKPSKIEV | 46 | Q9BUY7 | |
| LMALVVFVGVKYVNK | 261 | Q9Y666 | |
| NYPETLKFMLIVKAT | 181 | Q9UDX4 | |
| IVKATKLFPVGYNLM | 191 | Q9UDX4 | |
| VALIVFVLGSGMYKK | 211 | P46059 | |
| ALVVFAMGSKIYNKP | 231 | Q16348 | |
| IIFKKEMDPVTQLYT | 186 | Q13740 | |
| MLTKLKFEVFQPGDY | 556 | Q9UL51 | |
| IIREGTIGKKMYFIQ | 571 | Q9UL51 | |
| KEPEIMKNIIGFYTK | 1261 | Q96RY7 | |
| AKITKYLGIINMFFI | 886 | Q86YS7 | |
| EMVLKVIAFKPKGYF | 1251 | Q01668 | |
| AGIPNFILKMYETNK | 811 | Q5VW36 | |
| KTVIIKGFMSKYDPE | 2596 | Q8TE73 | |
| GTLKTFKMEYENPIT | 281 | Q2NKX8 | |
| CMKIPTGQEYAAKII | 31 | Q13557 | |
| LDKLISLFYGVVTPM | 306 | Q8NGS6 | |
| TTMQFKLVYKTGDVP | 91 | Q9BZA8 | |
| EISYGIKMILPVSEK | 276 | Q9UN75 | |
| YVILQLSTAPGMKFK | 46 | Q86XP0 | |
| LPMTDLDIKFQYRGK | 221 | O14896 | |
| VFQLGKKYQIFIPMV | 1181 | P42345 | |
| CFMSGPVLYQEKLLK | 1371 | A6NES4 | |
| KKPAVLYRFLLETMA | 1581 | A6NES4 | |
| IFYKPNTAMLLGDAK | 1056 | Q13423 | |
| VITPKMLGNFLYKQN | 76 | Q8NH10 | |
| VKMDVLNAFKYPLLI | 821 | Q9P2B2 | |
| FTLKRYKGVPAITQM | 276 | A4D263 | |
| PFVKVYLLQDGRKMS | 321 | Q8IV01 | |
| SIMVGIYGKIFIVSK | 211 | Q9P1P4 | |
| VKKYFLPIIEMVPQF | 271 | Q93008 | |
| PKGMDEQLTSLKVLY | 1511 | P46939 | |
| LKMQYATGPLLKFQI | 31 | P62341 | |
| TPVYRLGSNDKEIMK | 341 | Q9GZM7 | |
| GYILPDITKDELFKM | 241 | Q9P015 | |
| IYNKSIIEGPIIKLM | 1346 | A6NHR9 | |
| IYLKAIQGILGKSMP | 186 | Q93075 | |
| ELMGKSGIFPKNYIQ | 771 | Q5HYK7 | |
| VTGLNPKTKYILLMD | 91 | Q99593 | |
| PYRLKSSMVDKIFEG | 2166 | P12259 | |
| VKTKPLSMLYVDNGR | 316 | Q96S42 | |
| IVKDSFLLYMKPDSG | 256 | Q13393 | |
| FVYLSVLMASKPKEV | 491 | Q9H9A7 | |
| LEKYGIQMPSFSKIG | 186 | Q13576 | |
| DPIVKILGSDYNTMK | 131 | Q5T2S8 | |
| KAVLEDPMLKFSGLY | 36 | Q8NEB9 | |
| KNGDMVIPSDYFKIV | 376 | Q92859 | |
| KPNTLYEFSVMVTKG | 921 | Q92859 | |
| AQSKRGILTLKYPME | 721 | P0CG39 | |
| LVKIYMNLEKPDFIN | 201 | Q99460 | |
| AAGVVTMPQYLKKRF | 131 | Q2M3M2 | |
| LEKLPGLVFLYMEKN | 146 | P51888 | |
| MPYEIKKVFASLPQV | 1 | O75083 | |
| LKGMLEYEPAKRFSI | 286 | Q15831 | |
| YSIQKAMLKDSGPLF | 101 | Q15054 | |
| KPYKILVISADSGMI | 596 | Q9UBF8 | |
| IDKKYETVIMPVFGI | 531 | Q9Y5B9 | |
| AIGVLIYMDQTKFPI | 276 | P02786 | |
| YKGKDLSMIVLLPNE | 236 | P29508 | |
| VLLKAGMTVKQAVLY | 646 | Q13433 | |
| NKAASYFGMKIVRVP | 246 | O95470 | |
| ILPIMFASLYKISKE | 391 | Q15172 | |
| GLYLKPITKMTISVA | 21 | Q02040 | |
| MELLPEAKKYIVQSG | 196 | P54922 | |
| KVVGMTLFLLYFPQI | 16 | Q9NY25 | |
| KEVYMTPLRGVKATQ | 926 | Q9BPX3 | |
| YPINLAAIKMQTKVV | 1436 | Q7Z460 | |
| ILKYIETLAKQMDPG | 796 | O75122 | |
| LEGKIMPVKYEENSL | 156 | O75829 | |
| NVELTKPMQILYKGT | 2081 | A5YKK6 | |
| KKAPYESLIIDGLFM | 371 | Q9Y6X2 | |
| NMLTKETPETFYIGK | 1151 | Q7KZ85 | |
| FINAVKEKYGIEPTM | 971 | A0AVT1 | |
| GPLLKSAMVKFYNVR | 316 | Q9NRJ4 | |
| SAMNIKLGPALKIYA | 836 | Q8IXK0 | |
| FLDEVMKKYGSLVPL | 506 | Q96HI0 | |
| VTEFPIIKMYKKGEN | 461 | Q9P2K2 | |
| EFPVLKADGIKYIMI | 476 | P55060 | |
| QLPEEGLKFMVYLQK | 56 | A0A087X0M5 | |
| IPMAKSYVLKNGESL | 1901 | Q96RL7 | |
| VQMAGKKDYPALLSL | 41 | Q9H3J6 | |
| NYLIGKIKAMVAQPA | 321 | Q9BZQ8 | |
| EAMLFKGPNVYKKTV | 1146 | O60673 | |
| LKSYDFPIGMGIVKR | 541 | Q9UHI7 | |
| KILGIPYKNNDLSMF | 231 | Q9UIV8 | |
| GVLVAEVIKFYFPKM | 36 | Q9Y4P9 | |
| MNFSLPEKLEYIVTK | 2606 | Q15413 | |
| SMAPLGAQYKLLVTK | 151 | Q9NXL6 | |
| DVIAKVAFKMYLGIT | 76 | O43617 | |
| LAQKFGYKLVMVPEL | 236 | Q9NS62 | |
| KGIPQTMAAFGLKYL | 101 | Q9GZP7 | |
| KQVKDMYLIPLGATD | 1306 | Q92576 | |
| YPKFSKAIVINGILM | 166 | Q96MV1 | |
| LEMPDNLYTFVLKVK | 266 | Q9UQQ2 | |
| YKGKDLSMIVLLPNE | 236 | P48594 | |
| GSLMAAKEIEKYPLQ | 181 | Q687X5 | |
| PKGMAVDKNGLIYFV | 1286 | Q9P273 | |
| KEALPKAAFQYGIKM | 496 | Q13123 | |
| LPDMLKYVIEFASTK | 441 | Q96RU2 | |
| GEPMIALTTIFQKYL | 491 | Q5VIR6 | |
| VAIVKLAIYGMLPKN | 101 | Q9BYD1 | |
| IFLEKMGQKIAPYSV | 91 | P78527 | |
| KIVGSTSFPVKAYVM | 61 | Q9BS86 | |
| SLGYEVMKPDVIFKL | 46 | P51523 | |
| VGVFQKSLGLMIPYK | 1081 | Q8N9V7 | |
| KVEKMYVPALIFGQL | 131 | P11388 | |
| LLELKAVPAYMTGKL | 156 | Q9HBG4 | |
| KGYNLLKPMGKVVTY | 271 | Q99536 | |
| VVGKILYELSMKLTP | 356 | Q9P0Z9 | |
| FPLVKAAVQKAIPMY | 141 | P36543 | |
| GMNPKTKYILLIDIV | 106 | P57082 | |
| YDFIPSAKLKLSQGM | 686 | Q9Y4F4 | |
| VVRLGEVPYKMVKGF | 696 | Q01831 | |
| VFIGLYEKMEQVPKL | 171 | O15050 | |
| KKVIEINPYLLGTMA | 91 | P28074 | |
| SKGIIKQFLGYVPIM | 126 | Q9H9Y6 | |
| KQFLGYVPIMVKSKL | 131 | Q9H9Y6 | |
| LVKGKSMPYDFDIRV | 326 | Q8IWU6 | |
| QGDPIMTVKKAYFTI | 281 | Q96GX1 | |
| SKLIDRVYKGIPMNI | 91 | P35125 | |
| IDYAQFLPKIDGKKM | 1371 | P35125 | |
| QGLMKEYLLSFPAGK | 631 | Q96JC1 | |
| MKVKAPTYIGLSNIL | 201 | Q8NFZ6 | |
| SVTKPYVIMLLEDGK | 46 | Q9NR11 | |
| KSVQVDYMKTILFIP | 121 | Q8WU03 | |
| VRNLTYPLKKGYMIV | 311 | P20592 |